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Abstract 
 A novel fluorescent sensor was designed and synthesized to detect hydrophobic 
amines and was used to extract them from synthetically prepared vesicles. This sensor 
had a higher affinity for diamines than primary amines, providing a fluorescence decrease 
upon binding both analytes. This sensor bound longer chain amines such as decylamine 
and 1,10-diaminodecane, better than shorter chain amines such as octylamine. This 
binding is influenced by both hydrophobic effects and electrostatic interactions between 
the sensor and analyte, driven by the hydrophobic cavity on the sensor. The sensor also 
unexpectedly binds to spermine and spermidine, however, with an increase in 
fluorescence. The mechanism for this phenomenon is not yet understood. The sensor 
showed it is possible to remove hydrophobic amines from synthetic veiscles, which can 
be applied to biological systems. A fluorescent sensor for glycolipids was also attempted 
to be synthesized by several different methods, incurring a new synthesis through 
redesigning the synthesis.  Each method provided undesired products, decomposition, or 
no reactivity. Initial redesigns were due to complications in solubility of the carbazole 
aldehyde. Elongating the ester chain enhanced the solubility, but it remained unreactive 
towards any of the attempted reactions. This redesigned the sensor with a protected acid 
group that has been tested towards amide bond formation reactions to install the boronic 
acid or a haloarene, which will then undergo a Miyaura Borylation to install the boronic 
acid. If this does not prove successful, it will require alternative synthetic methods to 
install the boronic acid.   
 
 
 
	 1	
Chapter 1 Molecular Recognition 
1.1 Overview 
Research in molecular recognition originated in 1967 when Charles J. Pedersen 
discovered crown ethers.1 This accidentally synthesized dibenzo[18]crown-6 1, was 
found to have remarkable solubility properties. Specifically, it was only slightly soluble 
in methanol, while being more so when alkali metal salts were added. This led Pedersen 
to synthesize many similar compounds, such as 2 which shows strong binding affinity for 
K+ and 3 for Na+.2 The oxygen atoms are directed to the interior of the ring leaving the 
hydrophobic ethylene units exposed to the organic solvent. This placement permits crown 
ethers to solubilize otherwise insoluble ions in organic media.  
 
      
          1     2               3 
    dibenzo[18]crown-6        [18]crown-6      [15]crown-5 
The Nobel Prize in Chemistry was awarded in 1987 to Donald J. Cram, Jean-Marie 
Lehn and Charles J. Pedersen for their “development and use of molecules with structure-
specific interactions in high selectivity”, which included Pedersen’s work with crown 
ethers. A large number of crown ether derivatives have subsequently been prepared 
substituting the oxygen in the ring with a nitrogen 4 or sulfur 5. These new crown ethers 
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have achieved selective recognition of alkaline earth metals, mercury, lead, and various 
transition metals.  
 
     
           4                      5 
        cyclen               1,4,7-trithiacylcononane 
Work since the 1960’s has gradually established molecular recognition as a new field 
of supramolecular chemistry. This work has progressed from the recognition of simple 
ions, including metal cations and halide anions to much more complex guests. Some 
examples include drugs3-4, hydrogen peroxide5, chemical warfare agents6-9, sugars10, 
carboxylate11, phosphate12, and adenosine triphosphate (ATP)13, thus creating a vast array 
of new and diverse receptors.   
Molecular recognition involves the selective binding of a host complex to a guest 
through reversible non-covalent electronic and structural bonding interactions.2 A host 
complex is comparable to an enzyme where its guest would be a substrate. Similarly, a 
synthetically made host molecule is designed to bind an intended guest. These binding 
interactions include cation-π interactions (5-80 kJ mol-1), dipole-dipole interactions (5-50 
kJ mol-1), hydrogen bonding (4-120 kJ mol-1), hydrophobic forces, ion-dipole interactions 
(50-200 kJ mol-1), ion-ion interactions (100-350 kJ mol-1), π-π stacking interactions (0-50 
kJ mol-1), as well as van-der Waals forces (<5 kJ mol-1; variable).2 Each of these 
HN
HNNH
NH
S S
S
	 3	
interactions are weak, ranging 0-350 kJ/mol, in comparison to covalent bonding 
interactions, 180-854 kJ/mol.14 A common problem in developing these host complexes 
is the design, making the host selective for one or a very limited number of chemical 
species.  
Self-formation of micelles in water, DNA base pairing, protein folding, and enzymes 
binding to substrates are all examples of molecular recognition processes. While these 
processes are predominantly non-covalent bonding (and therefore reversible) interactions 
(Figure 1.1), more emphasis has been placed on processes that form reversible covalent 
bonds, such as boronic acids to form boronate esters when binding to saccharides or 
catechols. 
 
Figure 1.1: Reversible host-guest interaction 
 
While it is a novel feat to selectively recognize a chemical species via a synthetically 
created scaffold, it is also essential to provide a signal or measurable change to inform us 
that this specific chemical bonding event has occurred. When Pedersen placed KMnO4 
into benzene containing the dibenzo[18]crown-6 1 the solution changed from colorless to 
a purple color1. Unfortunately, a change in color is not an inherent quality of host/guest 
interactions, indicating the importance of developing chemical sensing probes, which will 
be discussed in the following chapter. 
	 4	
1.2 Hydrogen Bonding Interactions 
A hydrogen bond is a bond between a donor group possessing an acidic hydrogen 
and an acceptor with a lone pair (often a nitrogen, oxygen, or fluorine).14 For example, 
two water molecules can interact together to form a hydrogen bond between the hydrogen 
of one molecule to the oxygen of another, denoted by a dotted/dashed line, as seen in 
Figure 1.2a. One water molecule can be involved in hydrogen bonding with four other 
water molecules, two as a donor and two as an acceptor (Figure 1.2b).  
(a)     (b)  
Figure 1.2: (a) hydrogen bonding between two water molecules (b) hydrogen bonding 
network 
 
An example of the importance bonding in biological systems is seen in DNA base 
pairing (Figure 1.3). Here we see the pairing of thymine with adenine forming two 
intermolecular hydrogen bonds and guanine with cytosine forming three intermolecular 
hydrogen bonds.  
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Figure 1.3: DNA base pairing 
 
Hydrogen bonding receptors work best in organic mediums, where the polar host 
and guest would favorably interact with each other instead of the non-polar solvent. In 
polar solvents such as water, the host and guest are well solvated requiring the 
displacement of enthalpically favorable solvent shells for the host and guest to bind, 
significantly shifting the equilibrium away from the host-guest complex. 
 Hydrogen bonding has been applied in many sensors or receptors including 6 
which shows a binding affinity towards glutaric acid, Ka = (1.0 ± .2) x 104 M-1.15 
Furthermore, it was reported that 7 had a significantly higher binding affinity to glutaric 
acid, but was beyond the range to be determined via 1H NMR by Hamilton with  Ka > 5 x 
104 M-1. The titrations were performed in DMSO, thus the analytes are not able to have 
many hydrogen bonding interactions with the solvent and therefore interact with each 
other. However, the authors found upon addition of 12 % D2O the Ka = (8.5 ± 1.5 ) x 103 
M-1 and 25 % D2O Ka = (4.8 ± 2.5) x 102 M-1, demonstrating that synthetic hydrogen 
bonding receptors typically only operating in nonpolar solvents can still bind strongly in 
competitive solvents.  
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1.3 Hydrophobic Interactions 
1.3.1 Overview 
Hydrophobic interactions can be described by the immiscibility of hexane (or oil) in 
water. Water posses a large hydrogen bonding framework that must be disrupted for the 
addition of any solutes to create a solution. This disruption is energetically unfavorable in 
comparison to other aprotic solvent systems.  When adding hexane to water, hexane 
disrupts the strong hydrogen bonding framework in water replacing them with weaker 
dipole-dipole and van der Waals interactions. To minimize this energetic loss, the hexane 
molecules associate together decreasing the water-solute interactions and therefore 
increasing the water-water hydrogen bonding interactions (Scheme 1.1). This type of 
interaction is the process of how micelles form when lipids are added to water.   
 
Scheme 1.1: Hydrophobic effect of hexane (or other oils) in water. 
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Molecular recognition has taken advantage of hydrophobic interactions by creating 
hydrophobic cavities to encapsulate hydrophobic guests and as delivery units for 
therapeutic drugs. One of the first examples published in this area was the use of 
cyclodextrin (CD), a cyclic cup-shaped oligosaccharide consisting of 6-8 repeat glucose 
units, to create inclusion compounds.16  
 
(a)  (b)  
Figure 1.4: (a) γ-cyclodextrin (b) γ-cyclodextrin toroid structural arrangement 
The structure of cyclodextrin (Figure 1.4a) is influenced by the network of intramolecular 
hydrogen bonds present on the top and bottom surfaces of the cup. As these hydroxyl 
groups are involved in hydrogen bonding this makes the interior cavity less polar creating 
a hydrophobic environment promoting the encapsulation or inclusion of hydrophobic 
guests.  
Many derivatives of cyclodextrin are available each differing in ring size (α = 6, β = 
7, or γ = 8 glucose units), providing the ability to select among them based on guest size 
and fit within the cavity. The α-CD has an interior cavity size of 5.7Å, ß-CD is 7.8Å and 
γ-CD is 9.5Å.17 CD’s have proven to be a valuable tool in chemical sensing and drug 
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delivery for a wide range of guests. For example, research has shown that hydroxypropyl-
ß-cyclodextrin has remarkable properties facilitating the removal of cholesterol from 
tissue culture cells (Scheme 1.2).18-19  
 
Scheme 1.2: Encapsulation of cholesterol by ß-cyclodextrin 
ß-cyclodextrin is also widely used in the application of drug delivery. As many 
drugs are minimally water soluble, ß-CD is used to solubilize the drug for oral and ocular 
delivery20. Examples include Dexamethasone, Diclofenac, Pilocarpine, Digoxin, and 
Danazole shown in Figure 1.4. The binding constants for the drug/CD complexes range 
from 100 to 20,000 M-1. When the drug is administered either by injection or orally, the 
drug/CD complex becomes very dilute, releasing the free drug to permeate through 
biological membranes. Evidence has shown that a 1:100 dilution of the drug/CD 
complexes reduces the complexed drug from 100% to 30%20.  
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Figure 1.5: Select drugs that use CD’s for delivery and their delivery process20 
 
This creation of a hydrophobic toroidal cavity to encapsulate guests has lead to the 
discovery of more hosts possessing notable host-guest properties, such as calixarenes and 
cucubiturils.  
1.3.2 Calixarenes and Cucubiturils 
The structure of calix[4]arene (Figure 1.6) was established in 1970 by Gutsche21-22 
and colleagues. It is synthesized via the reaction of para substituted phenols with 
formaldehyde and can vary in size by the number of phenol units. The substituents can 
vary as well. As shown in Figure 1.6b, calix[4]arene forms a cavity much like CD’s and 
has been used to detect a wide array of species including anions23, cations24-26, and other 
small organic guests.  
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(a)  (b)  
Figure 1.6: (a) Calix[4]arene structure (b) Calix[4]arene molecular model from Spartan 
Recent research on binding of L-amino acids with 
calix[4]arenehydroxymethylphosphonic acids have shown binding constants that vary 
between 20,000 M-1 and 50,000 M-1, as indicated in Table 1.1.27 
Table 1.1: Binding constants of L-amino acids with meso calix[4]arene-bis-α-
hydroxymethyl phosphonic acid 
L-amino 
acid 
Ka, M-1 
Gly 31,234 
Ala 47,299 
Pro 40,082 
His 48,189 
Lys 42,572 
Asp 29,947 
Arg 35,992 
Phe 30,185 
Trp 27,490 
Tyr 20,983 
OHOH HOOH
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Cucubiturils are synthesized by the reaction of glycouril with formaldehyde (Scheme 
1.3). This macrocycle was first synthesized in 1905 by Behrend et al28; however, the 
structure wasn’t confirmed until 1981 by Freeman et. al29.  These structures form a 
hydrophobic cavity, with the inner cavity size increasing by the number of repeat units. 
Figure 1.7 shows a 3-D representation of some of the cucubituril derivatives, thus 
demonstrating how the size of the cavity increases as the number of repeat glycouril units 
increases.  
 
Scheme 1.3: Synthesis of cucubiturils 
 
 
Figure 1.7: 3-D representation of some common cucubituril derivatives 
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In a recent publication30 Isaacs et. al. has shown cucubit[7]uril (CB[7]) to possess 
remarkable binding properties. Specifically, he has demonstrated that it possesses a 
binding constant of 7.2 x 1017 M-1 with the diamantane diammonium guest 8, an 
attomolar binding constant. This is one of the tightest binding monovalent non-covalent 
complexes in pure water (D2O) ever reported. In D2O buffered with 50 mM NaO2CCD3 
the binding constant was slightly less but still very tight, 1.9 x 1015  M-1. 
 
8 
Their findings supplemented the known ions that CB’s can bind, further illustrating that 
binding of hydrophobic trimethylammonium compounds, iron sandwich complexes, 
multiple adamantane type guests, and acridine-3,6-diamine can be accomplished with 
binding constants varying between 2.5 x 104 – 3 x 1013 M-1. 
1.4 Reversible Covalent Binding 
1.4.1 Overview 
As mentioned above, molecular recognition involves non-covalent bonding 
interactions. However, interactions that are covalent in nature but exist in equilibrium can 
also achieve a similar purpose. Examples of reversible covalent bonding interactions 
include those of phenylboronic acids with diols (Scheme 1.4) and electron deficient 
carbonyls with amines (Scheme 1.5). Boronic acids are widely used for their interactions 
N
NI
I
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with sugars, catechols, and other diols. This is a potentially valuable property in the 
medical field as a potential diagnostic tool for the monitoring of blood glucose levels of 
patients diagnosed with diabetes31.  
 
 
Scheme 1.4: Phenylboronic acid binding with diol 
 
 
Scheme 1.5: Coumarin aldehyde binding an amine32 
Phenylboronic acid binding has been widely studied since the discovery of boronic 
acids solubilizing saccharides and polyols by Kuivila et al.33 Since then numerous 
publications have demonstrated sensors targeting saccharides34-41, nucleotides and 
carbohydrate transporters42-49, and as affinity ligands for the separation of carbohydrates 
and glycoproteins50-55.  
 
Scheme 1.6: Phenylboronic acid binding to catechol 
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Springsteen and Wang demonstrated that phenylboronic acid can bind to catechol 
with an equilibrium constant of 800 M-1.56-57 This discovery inspired the development of 
fluorescent sensors for dopamine and norepinephrine 958, and glucosamine 1059 from the 
Glass group. Sensor 9 was selective for the binding of dopamine and norepinephrine, but 
did not bind glucosamine very well due to the large size of the binding cavity. This lead 
to the development of sensor 10, which showed highly selective binding for glucosamine 
Ka = 4,100 M-1 over other catechols such as norepinephrine (Ka = 25 M-1)59. 
 
      
9             10  
Wang also performed additional research into the relationship between pKa, pH, and 
binding constants between the interactions of phenylboronic acids and diols. It was found 
that (1) a Hammet plot can describe the relationship between pKa of monosubstituted 
phenylboronic acids and its substituents, (2) the optimal binding pH is not always above 
the pKa of the boronic acid, and is affected by the pKa values of the boronic acid and the 
diol, and (3) boronic acids with lower pKa values do not always have greater binding 
affinities.60 
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1.4.2 Sugar Binding 
Sugars such as glucose 11 and fructose 12 have multiple diol groups that allow them 
to successfully bind to phenyl boronic acids. The first fluorescent sensor for 
carbohydrates was presented by Yoon and Czarnik in 199261. Since then a wide array of 
boronic acid sensors have been made, many purposed for incorporation into blood sugar 
monitors for diabetic patients10, 62-63. Interestingly, the desire for blood sugar monitoring 
has been advanced to commercial production of contact lenses that change the color of 
the lens to alert the wearer of a drop in circulating glucose levels64. Furthermore, peptide 
boronic acids have demonstrated the capability of binding to the tertiary structure of  
HIV-1 RRE IIB in the low micromolar region65-66. 
      
  11       12 
 Shinkai developed one of the first phenyl boronic acid sensors selective for 
glucose over other monosaccharide sugars as evidenced by circular dichromism.67 
Specifically, the diboronic acid shown in Scheme 1.7 bound glucose 190 times more 
favorably than the next strongest binding analyte, maltose.  Since then it has been 
established that the relative affinity of boronates for diols in most carbohydrates is of the 
order cis-1,2-diol > -1,3-diol > > trans-1,2-diol68. This feature explains why some sugars 
intrinsically bind better than others.  
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Scheme 1.7: Shinkai Sensor for D-glucose 
1.5 Conclusion   
Molecular recognition has come a long way in the past 50 years. It has grown in 
popularity for not only it’s ability to recognize molecules, but to also help us understand 
many biological processes. Molecular recognition is most known for using non-covalent 
interactions, however a growing use of reversible covalent interactions is being explored. 
These interactions between the host and guest depend on the shape, size and charge 
between the host and guest. This specificity allows for selective interaction between 
targeted guests and have promoted a growing number of medicinal applications. The 
novelty, complexity, and possible medicinal applications of these applications has created 
groundbreaking new fields in chemistry, with one of the most notable being fluorescent 
chemical sensing. 
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Chapter 2 Fluorescence Chemical Sensing 
2.1 Overview 
A chemical sensor transforms chemical information (presence, concentration, 
activity) into an analytical signal that can be quantified. Fluorogenic probes are a unique 
class of chemical sensing probes, an area that was pioneered by Gregorio Weber. Weber 
is responsible for the development of probe chemistry, by being the first to demonstrate 
the use of dansyl chloride as a fluorophore69. Figure 2.1 illustrates a few examples of the 
many known fluorophores.  
 
 
Figure 2.1: A few common fluorophores 
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Fluorescent molecules are organic compounds containing conjugated π-systems. 
The fluorescence event occurs from the transition of an electron from the HOMO 
(highest occupied molecular orbital) to the LUMO (lowest unoccupied molecular orbital). 
The larger the conjugated π system is, the smaller the HOMO-LUMO gap becomes, 
resulting in an emission at longer wavelengths.  
Sensors are either weakly fluorescent or nonfluorescent until a bonding 
interaction occurs, indicating a chemical change. Fluorescent sensing, especially near-IR 
fluorescent probes, allows for the use of these probes for in vivo and in vitro imaging. A 
sensor possesses a recognition site intended to bind to a desired guest, which is tethered 
to the fluorophore by a spacer unit (Figure 2.2). To “turn-on”, the fluorescent sensor 
binds to a guest causing an enhancement in fluorescence. Alternatively some sensors are 
“turn-off”, being quenched by the guest and thus show a decrease in or loss of 
fluorescence signal. Measuring this increase or decrease in fluorescence due to the 
binding event allows us to determine a binding constant, Ka. 
 
Figure 2.2: A Turn on fluorescent sensor schematic representation 
2.2 Fluorescence Basics 
Fluorescence is defined by IUPAC as a luminescence occurring when a substance 
is irradiated by (absorbs) electromagnetic irradiation. The scheme in Figure 2.3 shows the 
process of how fluorescence occurs. A molecule or fluorescent dye begins in its ground 
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electronic state (S0) and absorbs electromagnetic radiation, becoming excited to a higher 
singlet excited state (S1 or S2), each composed of their own vibrational levels. Once 
excited, the molecule can undergo a non-radiative decay or internal conversion between 
the two states which have the same spin-multiplicity70. It is then followed by a vibrational 
relaxation to the lowest level of the S1 state. Once in the lowest S1 level, the molecule can 
return to its ground electronic state, through the emission of photons, which is 
fluorescence. The photons that are released are of lower energy than the absorbed 
photons, thus giving the fluorescence wavelength a longer wavelength than the 
absorption. This difference between the absorption maxima and the fluorescence 
wavelength maxima is known as a Stokes’ shift (Figure 2.4). For example, excitation of 
coumarin 6 at 420 nm results in a fluorescence max at 500 nm providing a 80 nm Stokes’ 
shift. These maximas are dependent on factors such as the structure of the fluorophore 
and the solvent. The timescale of this process is on the order of 10-8 to 10-11 seconds.71 
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Figure 2.3: Jablonski Diagram 
 
Figure 2.4: Stokes Shift 
Absorption will not always lead to fluorescence. A separate process can occur 
upon excitation and relaxation to the lowest excited state S1. The molecule can undergo a 
non-radiative transition (intersystem crossing) to the triplet state T1. This is the transition 
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between isoenergetic vibrational levels belonging to electronic states of different 
multiplicities.70 Upon relaxation from the T1 state to the S0 state, the emission of photons 
is called phosphorescence. While it is commonly said that this transition from T1 to S0 is 
electronically forbidden, it can occur due to spin-orbital coupling, which occurs over a 
longer period of time on a scale of seconds to minutes. This is what gives stick on stars 
their ability to glow in the dark. 
Quantum yield (Φ) indicates how efficiently a molecule will behave as a 
fluorophore. It is calculated by measuring the ratio of photons emitted to photons 
absorbed. A quantum yield of 1.0 would indicate that all of the photons absorbed are 
emitted. Energy transfer due to fluorescence quenching causes the quantum yield to 
decrease. The energy can then be transferred to the solvent, another chemical species in 
the solution, or another excited molecule.  
2.3 Overview of Fluorescent Sensing 
Fluorophores are designed such that their spectra change as a function of the 
concentration of added analyte, such as biological amines, pH, anions, or cations. 
Fluorescent sensing can use a variety of quenching mechanisms including photoinduced 
electron transfer (PET), intramolecular charge transfer (ICT), or Förster Resonance 
Energy Transfer (FRET). These quenching mechanisms allow probes to selectively give a 
turn-on or turn-off response upon binding to their intended analyte.  
2.3.1 Photoinduced Electron Transfer 
Photoinduced electron transfer, PET, involves a light induced transfer of an 
electron resulting in a quenching effect. Upon excitation, a fluorophore has two half filled 
orbitals with a significant energy gap between them. If another molecule not conjugated 
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to the fluorophore has a HOMO or LUMO within this HOMO/LUMO gap, a 
photoinduced electron transfer can happen by one of two methods, a-PET or d-PET.  
When the HOMO of the tethered system falls within the energy gap of the 
fluorophore, this process is called acceptor PET, a-PET. The fluorophore has a half filled 
HOMO, allowing an electron from the HOMO of the other molecule to be transferred 
into the lower energy HOMO, quenching the fluorescence. In this case the fluorophore is 
acting as an electron accepter and this process is termed a-PET (Figure 2.5). An a-PET 
designed sensor can be designed to be quenched by this process until it binds to the 
analyte of interest, changing the HOMO/LUMO energy levels and giving rise to 
fluorescence as depicted in Figure	2.6. 
 
Figure 2.5: a-PET frontier molecular orbital quenching mechanism 
 
Figure 2.6: non quenched a-PET system 
 
 If instead the LUMO of the other molecule was in the energy gap, as 
demonstrated in Figure 2.7, the quenching process is d-PET (donor PET). The electron 
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that was excited to the LUMO of the fluorophore is transferred into the lower energy 
LUMO of the acceptor molecule before it can fluoresce. However, upon binding the 
energy of the LUMO rises, giving rise to the fluorescence as seen in Figure	2.8. 
 
 
Figure 2.7: d-PET Frontier molecular orbital quenching mechanism 
 
Figure 2.8: d-PET non-quenched system 
 
The fluorophore system is quenched in Scheme 2.1 by an electron in lone pair of 
the nitrogen atom donating into the fluorophore system (a-PET). When the sensor binds 
with HPO42- the electrons in the lone pair become coordinated with the hydrogen atom 
giving rise to its fluorescence enhancement.69 
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Scheme 2.1: a-PET quenched fluorescent probe69 
2.3.2 Determining Stoichiometry of binding 
When a titration reveals that binding could be occurring, a Job plot titration is 
performed to determine the stoichiometry of the binding between the host (H) and guest 
(G): 1:1, 1:2, 2:1, etc. To perform this, the concentration of the host and guest remain 
constant while varying the mole fraction of the guest. They are then titrated and measured 
over UV or fluorescence intensity signals. A plot is then created using the mole fraction 
guest vs. UV signal, which provides a curve with a maxima corresponding to the 
stoichiometry of the complex formed when H and G bind. Figure 2.9 illustrates a plot 
with a 1:1 stoichiometry.  
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Figure 2.9: Job plot showing 1:1 binding 
2.4 Conclusion 
Fluorescent sensors provide a valuable method of detection of multiple analytes, 
which can be selective when a sensor is properly designed. Through many different 
quenching mechanisms such as  PET, FRET, ICT, a sensor can be designed such that it 
gives a desired “turn-on” or “turn-off” response when the analyte is present. Fluorescent 
sensing also allows us to predict the ratio of binding between the host and guest when a 
Job plot is analyzed.  
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Chapter 3 Lipids and Glycolipids 
3.1 Overview 
Lipids are biological molecules that are insoluble or weakly soluble in water, while 
being soluble in fat or organic solvents such as toluene, ether, and chloroform72. Lipids 
are the primary components of cellular membranes, protecting the cell and allow 
selective cellular processes in the body to be achieved. Lipids can contain long 
hydrocarbon chains such as in fatty acids and isoprenes, or multiple rings similar to those 
found in steroids. Their diverse structures present five main types of lipids: fatty acids, 
phospholipids, sphingolipids, steroid lipids, and triacylglycerol’s.  
Fatty acids, FA, are carboxylic acids with long chain hydrocarbons that can be 
saturated, unsaturated or polyunsaturated. Their aliphatic chains can range from 12-20 
carbon atoms73, with the C16 and C18 species including oleic acid (shown in Figure 3.1), 
stearic acid, linoleic acid, and palmitic acid being among the most abundant found in 
plants and animals. Fatty acids are important as they represent a major component of the 
other lipid classes, as they contain one or more fatty acid esters in their structures. In 
mammals, fatty acids are found in adipose tissues which serves as energy storage74. 
 
Figure 3.1: A few common fatty acids 
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Phospholipids (Figure 3.2) are the major lipid component of cellular membranes and 
are responsible for some of the cell-to-cell signaling pathways in the body. They contain 
a glycerol unit with two hydrophobic fatty acid tails and a hydrophilic phosphate group. 
Additionally, the phosphate group can be attached to a hydrophilic compound (-R) such 
as choline, serving as a headgroup. As these lipids contain a hydrophilic head and 
hydrophobic tails, they are termed amphipathic or amphiphilic. Common headgroups 
include choline, serine, ethanolamine, glycerol, and inositol (Figure 3.3), with choline, 
ethanolamine, and serine, accounting for 35-45%, 22-29%, and 12-19% of all 
phospholipids in cell membranes, respectively75. The fatty acid (hydrophobic tail) 
anchors the phospholipid into the membrane and the headgroup (hydrophilic headgroup) 
is on the exterior of the membrane exposed to the surrounding water environment.  
 
 
Figure 3.2: Phospholipid structure 
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Figure 3.3: Various headgroups of phospholipids (where R is the phospholipid) 
 
Sphingolipids are also a major lipid component of cell membranes. While 
phospholipids contain two fatty acid chains, sphingolipids contain a sphingosine 
backbone with one fatty acid residue attached to the 2-amino position of the sphingosine. 
Substitution of the terminal hydroxy group on the sphingosine with a choline phosphate 
ester results in a sphingomyelin, or with a sugar acetal, yields a glycosphingolipid or 
cerebroside, shown in Figure 3.4. 
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Figure 3.4: Sphingolipid examples 
Steroids contain four fused rings as illustrated in Figure 3.5. Cholesterol is the most 
abundant steroid found in mammals and the major component in membranes. It’s 
presence decreases membrane fluidity and inhibits fatty acids from crystallization by 
interaction between the fused ring system and the long tails of the fatty acids. 
Progesterone is an example of the progestogen steroid hormone found in humans that is 
responsible for the regulation of the female menstrual cycle, embryogenesis, and 
pregnancy. Dexamethasone, a synthetic corticosteroid drug, has been used in many 
medical treatments including treatment of inflammation, severe allergies, adrenal 
problems, arthritis, asthma, blood and bone marrow disease, kidney disease, skin 
conditions, and symptoms of multiple sclerosis76.  
sphingosine
HO
NH2
HO
HO
NH
O
O
P
O
O
O N HO
NH
O
O
O
OH
OH
OH
OH
spingomyelin cerebroside
	 30	
 
Figure 3.5: Steroid ring system and examples 
 
Bile acids are a group of steroids that assist in the digestion and absorption of fats 
and fat-soluble compounds in the intestines.77 Ursodeoxycholic acid, a bile abundant in 
bears, differs from chenodeoxycholic acid in the orientation of the hydroxyl group on the 
C7 position of the steroid backbone (Figure 3.5). Ursodeoxycholic acid has been used for 
the treatment of primary biliary cirrhosis and to dissolve gallstones. Chenodeoxycholic 
acid in combination of benzafibrate has been used for the treatment of Hepatitis C 
infections.77 
Triacylglycerols (or triglycerides, Figure 3.6) are fatty acid triesters of glycerol found 
mostly in the cytoplasm of adipose cells78. Triacylglyercol is a highly concentrated and 
efficient form of energy storage in animals. For example, in a 70 kg man who has fuel 
reserves of 100,000 kcal in triacylglycerols, about 11 kg of his total body weight consists 
of triacylglycerols. If this energy was instead stored as glycogen, his body weight would 
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be about 55 kg greater. About 7 kcal/g of energy is released from the complete 
oxidization of triacylglycerols, much higher than that of carbohydrates and proteins, 
which are about 4 kcal/g.78  
 
Figure 3.6: Example of a triglyceride 
3.2 Micelles and Vesicle Formation 
Micelles and vesicles are able to be formed with phospholipids, glycolipids and fatty 
acids. Upon addition to water a fatty acid will either come together to form a micelle, 
form a lipid bilayer, or form a vesicle.  In water, the polar headgroups will form a layer 
on the outside of the vesicle orienting the hydrophobic tails into the interior of the micelle 
as shown in Figure 3.7.  
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Figure 3.7: Micelle 
Fatty acids will form micelles once a specific concentration is present in solution. This is 
called the critical micelle concentration (CMC). When below the CMC micelles will not 
form, and above the CMC addition of more fatty acids result in the formation of 
additional micelles.  
3.3 Lipid Signaling 
Lipids are important in protein function and various signaling processes including 
cell proliferation, apoptosis, metabolism, and migration.77, 79 For example, anadamide (N-
arachidonoylethanolamide, AEA) is a cannabinoid neurotransmitter affecting memory80, 
sleep81, appetite82, and pain perception83. This appetite control is similar to the 
physiological effect seen with tetrahydrocannabinol (THC) in the body. Structurally 
similar (Figure 3.8) oleoylethanolamide (OEA) does not bind to cannabinoid receptors,  
and instead acts as a sleep-inducing fatty acid amide.84 Other studied signaling lipids 
include phosphoinositides, sphingolipids, eicosanoids, and fatty acids, all of which are 
important for cellular processes.79   
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Figure 3.8: Anandamide and oleoylethanolamide 
 
3.4 Lipid Recognition 
3.4.1 Alkane Recognition 
In 2003 Rebek reported one of the first alkane binding receptors85 13. Initially it was 
found to bind choline 14 with a Ka > 104 M-1, while carnitine 15 bound with a Ka of ~ 102 
M-1. Furthermore, they found that it did not bind quaternary salts, such as 
tetrapropylammonium. Upon testing dodecylphosphocholine they expected it would not 
insert its charged head, however, the research showed that the allyl chain did insert into 
the cavity.  It was found that the receptor recognizes alkanes in a helical (or U-shaped) 
conformation better than in the extended conformation, despite the 2-3 kcal per mol of 
strain. In an aqueous solution the molecule adopts a cup-like shape (Figure	 3.9) with 
water bridged between the benzimidiazole groups to form hydrogen bonds, which 
stabilizes the conformation giving it a hydrophobic cavity to bind these guests.  
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13 
 
Figure 3.9 
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 Ko et al86 discovered that long chain alkanes adopt a U-shaped conformation 
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similarities to the β and γ cyclodextrins they tested their capabilities of binding alkyl 
amines. They tested C12TA+  16 and found that it bound to both CB[7] and CB[8] in a 1:1 
stoichiometry. 1H NMR indicates that the doedecyl chain penetrates through the CB[7] 
cavity via the upfield shifts for protons C1-C7, with little other changes seen for C8-C12. 
All the protons for CB[8] showed a significant upfield shift in addition to intramolecular 
NOE between the terminal methyl group and trimethylammonium protons, which 
indicates the alkyl chain adopts a U-shape conformation inside the CB[8] cavity. 
Titrations performed by isothermal titration calorimetry (ITC) indicated the binding 
constant for CB[7] to be 5.8 x 105 M-1 and for CB[8] to be 2.8 x 105 M-1.   
 
16 
3.5 Glycolipids 
3.5.1 Overview 
 
Glycolipids are membrane-anchored lipids composed of a hydrophobic region 
containing two long hydrocarbon tails, and a polar region containing one or more 
saccharide residues (Figure 3.10). These carbohydrates extend from the phospholipid 
bilayer into the aqueous environment outside the cell where they act as recognition sites 
for specific proteins72. Glycolipids generally constitute about 5% of the lipid molecules in 
the outer monolayer and are also found in some intracellular membranes.  
N
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Figure 3.10: A simple glycolipid 
 
Glycolipids, or lipids with a carbohydrate head group (Figure 3.11), are important for 
cell-to-cell recognition72, associated with viral infection, inflammation and tumor 
metastasis87-89. Glycolipids also act as the antigens of the ABO blood types90 and are 
associated with diseases such as atherosclerosis91, cancer, and many glycolipid storage 
diseases92. Other forms of glycolipids include glycero-glycolipids and sphingo-
glycolipids.  
 
Figure 3.11: Glucocerebroside – a simple glycolipid  
3.5.2 Lipid Storage Diseases 
There exists a class of diseases called lipid storage diseases or lysosomal storage 
diseases where the body is unable to process lipids. The lysosomal storage disorders 
(LSD) are a group of about 50 diseases characterized by the accumulation of waste 
products in the lysosomes due to the loss of digestive function, resulting in the formation 
of large intracellular vacuoles. Gaucher’s Disease was first discovered by Philippe 
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Gaucher in 1882.93 It was the first identified LSD and is caused by the deficiency of the 
enzyme ß-glucosidase, also known as glucosylceramidase. The lack of this enzyme 
causes an accumulation of glucocerebrosides (glycolipids) in tissue macrophages.94 This 
accumulation leads to hepatosplenomegaly, bone marrow suppression, and bone 
lesions.95-97  
Gaucher’s Disease is known to affect 1 in as many as 450 births in the Jewish 
population or between 1 in 20,000 to 1 in 200,000 in the general population.98-101 
Treatment options include enzyme replacement therapy, and substrate reduction 
therapy.96, 102 More recently quinazolines have been proposed as selective ß-
glucocerebrosidase modulators.103 These quinazolines (Figure	 3.12) are very potent and 
have been shown to stabilize the misfolded mutant ß-glucocerebrodiase (GCase) over 
other enzymes, increasing its activity and concentration in cell assays. They have proven 
to be the most potent noniminosugar GCase modulators that may prove beneficial for 
treatment of Gaucher’s and Parkinson’s diseases. Additional LSD’s include Fabry 
disease, Nieman Pick, mucopolysaccharidoses (MPS), and Pompe Disease.  
 
Figure 3.12: Quinazoline modulators 
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3.5.3 Forssmann’s Antigen 
Forssmann’s antigen is a heterophilic glycolipid antigen possessing structural 
similarities to the blood group A antigen.104 Furthermore, the GBGT1 gene that encodes 
the Forssmann glycolipid synthase is evolutionarily related to the ABO blood group gene. 
It is present in non-human mammals including sheep, horses, dogs, and cats. Its structure 
was described in 1930 by John Forssmann and is shown in Figure	3.13. 
 
Figure 3.13: Structure of Forssmann’s antigen104 
3.5.4 ABO Blood Group 
The ABO blood group system was discovered by Austrian scientist Karl 
Landsteiner in 1900 and is an essential guide today for the success of blood 
transfusions.105 He was later awarded the Nobel Prize in Physiology or Medicine in 1930 
for his work. Lansteiner discovered the A, B and O blood antigens, but it wasn’t until 
1902 that the AB antigen was identified by Alfred von Decastello and Adriano Sturli.  
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Figure 3.14: Blood Group Antigens 
The blood group antigens are composed of specific sugars exposed on the exterior 
of red blood cells (RBC’s; erythrocytes), differing according to their blood type (Figure 
3.14).  The antigens differ by the linkage of the monosaccharides at the end of the 
carbohydrate chains. The antigenic portion is comprised of one or more carbohydrate 
chains connected to a ceramide or peptide backbone, which is embedded into the lipid 
bilayer of the cell membrane. Humans have antibodies to the A or B antigens, which they 
lack; group-B have anti-A, group-A have anti-B, and group O has both.  If a patient is 
administered the incorrect blood type during a transfusion, an immune response is 
triggered which can have fatal hemolytic consequences.106 Because group O lacks both 
the A and B antigens, blood type O is always in high demand with O (-) blood often in 
high demand. Table 3.1 shows the percentage of the U.S. population with the respective 
blood types.  
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Table 3.1: Blood Types by population in the U.S.106 
 Caucasians African-
American 
Hispanic Asian 
O (+) 37 % 47 % 53 % 39 % 
O (-) 8 % 4 % 4 % 1 % 
A (+) 33 % 24 % 29 % 27 % 
A (-) 7 % 2 % 2 % 0.5 % 
B (+) 9 % 18 % 9 % 25 % 
B (-) 2 % 1 % 1 % 0.4 % 
AB (+) 3 % 4 % 2 % 7 % 
AB (-) 1 % 0.3 % 0.2 % 0.1 % 
 
This immune response has lead to the inspiration of creating a “universal blood”. 
While O blood type works for transfusions to individuals with A, B and AB blood, often 
times it is in short supply and some hospitals may only have type O. Therefore, if there 
was a method to convert A, B or AB to the corresponding O blood type, it would 
theoretically provide an increase to the “universal blood” supply. This idea has lead to the 
creation of enzymes that can effectively cleave or remove the antigens from the red blood 
cells.107-108 
An early study published in 1982 converted B-type erythrocytes into universal O-
type blood cells, catalyzed by the use of an exoglycosidase from a coffee bean, α-
galactosidase.106 Selective cleavage of αGalNAc and αGal residues of the A and B 
trisaccharide antigens proved successful and the cell was able to survive transfusion. This 
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method was not practical, as it required large quantities of the enzyme for conversion. 
Later, subsequent attempts were pursued to implement the original vision of enzyme 
cleavage, but the desired levels of activity were unable to be achieved.109-110 The use of 
bacterial glycosidases showed improvements, but the enzyme activity was still 
insufficent.111 Thus, these "improved" methods also required larger quantities of enzyme, 
up to 60 mg per unit of RBC. 
In recent work Stephen Withers et al107 demonstrated a structure-guided directed 
evolution approach that was applied to Sp3GH98 (Streptococcus pneumonia) for the first 
time. Sp3GH98 cleaves the entire terminal trisaccharide antigenic determinants of both A 
and B antigens from selected linkages on RBC surface glycans; however, so slowly that 
its application was not feasable. Through the structure guided directed evolution, their 
goal was to enhance enzyme activity towards the cleavage of the Galβ-1,3-GlcNAc 
linkage of type 1A antigens (Figure 3.15, Figure 3.16). Their work showed an increase in 
the activity of the selective glycoside hydrolase and broadened the substrate specificity of 
Sp3GH98 towards the cleavage of the Galβ-1,3-GlcNAc linkage of type 1 chains. This 
was achieved without inhibiting the activity towards Galβ-1,4-GlcNAc type 2 chains. 
This sets the stage towards broadening the substrate specificity towards the Galβ-1,3-
GalNAc linkages of type 3 and 4 chains, which involves the A antigens 
specifically.Therefore, much more work is required before the production of completely 
universal blood is possible.. 
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Figure 3.15: Various saccharide chain types to which A antigens are present on 
erythrocytes and other cell types 
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Figure 3.16: Site of cleavage of A or B antigens with GH98 EABase of type 2 chains 
The benefit of creating a universal blood would aid in blood transfusions during 
surgery, or when the O blood type is in short supply, especially from casualties in large 
disasters. Additionally, it could aid in organ transplants between patients, helping to 
ensure the incompatible blood has been successfully removed. Therefore, it would be 
extremely benficial to futher the work towards this concept. 
3.6 Conclusion 
Biological lipids play a fundamental role in living organisms. Their role is valued in 
processess such as energy storage, signaling pathways, part of the cell membrane, act as 
steroids, and are involved in transport roles. Glycolipids in particular play an active role 
in many important diseases today that medicine seeks to cure.  
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Chapter 4 Molecular Tubes for the Detection and Extraction of 
Hydrophobic Amines from Vesicles 
4.1 History of Molecular Tubes 
4.1.1 Overview 
Lipid receptors are achieved by varying the size and shape of a hydrophobic cavity to 
the fit of the desired lipid, while placing hydrophilic groups on the exterior of the 
molecule to achieve water solubility. Our group has been interested in taking advantage 
of this knowledge and applying it towards the detection of biologically relevant lipids 
using molecular tubes. The inspiration for the scaffold of our cavity design comes from 
the dimerization of 2,7-dihydroxynaphthalene (Scheme 4.1). In the presence of an acid 
catalyst, 2,7-dihydroxynaphthalene can undergo a condensation with malonaldehyde 
tetramethyl acetal to produce a naphthalene dimer in efficient yield, providing a great 
hydrophobic cavitand112. This hydrophobic cavitand has nearly a right angle, is fairly 
rigid, and possesses a large hydrophobic area (Figure	4.1).  
 
Scheme 4.1: Condensation of 2,7-dihydroxynaphthalene 
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Figure 4.1: Geometries of naphthalene dimer 
 Previous computer modeling demonstrated linking the naphthalene dimers 
together by an odd number of atoms would produce an open tube structure, whereas an 
even number of atoms was more likely to deform the cavity. Furthermore, a tube linked 
by less than three atoms, would leave the resulting molecule highly strained, resulting in 
a highly difficult synthesis. Additionally, a CPK model of the tube with a one or two 
atom linker revealed that their hydrophobic cavities are too small for an alkyl chain. It 
was found that the size of the tube linked by a three atom linker was most complementary 
to the volume of extended alkyl chains, enabling the selective detection of alkanes over a 
cis/trans alkene. 
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Figure 4.2: Thioether Model 
 
A series of three atoms linkers were examined by our group including a thioether, 
amine, amide, and alkene 17a-d.  Energy minimized calculations showed that flexible 
linkers, such as the thioether linked 17a and amine linked 17b, are not rigid enough to 
retain an open cavity, and therefore tend to collapse and adopt a deformed structure due 
to hydrophobic interactions. An example of a collapsed model is showed in Figure 4.2. 
On the other hand, the amide and allyl groups are remarkable as they keep the tube 
structure open. Therefore these two were pursued in our group.  
4.1.2 Amide linked molecular tube 
Early work in our group lead to the creation and publication of an amide linked 
tube in 2004.113 The amide linked tube was synthesized starting with 2,6-
dihydroxynaphthalene 18.  
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22     21                8  
 
   
24       25 
 The amide sensor showed only small changes in the UV when titrated with fatty 
acids, however, the fluorescence data showed significant responses (Table	 4.1). The 
titrations were performed at pH 8.4 to maintain solubility of all species. The association 
constants of both the syn and anti tube inform us that as the alkyl chain length increases 
the affinity also increases. While the alkene tested has a carboxylic acid, alkenes also 
occupy a lot of space, and therefore are unable to be comfortably bound inside the cavity. 
Branching in the middle of the chain, as seen in 4-methyl-octanoic acid, suppresses the 
binding significantly (Ka = 71), but branching near the end of the chain is tolerated for 8-
methyl-nonanoic acid (Ka = 1,600). Heptanol, a neutral species, was found to bind better 
than the fatty acids of similar length (Ka = 4,900), as it avoids the negative-negative 
charge repulsion that the carboxylates face. Furthermore, heptylamine binds even better 
than its fatty acid counterpart due to the attraction between its positive charge at pH 8.4, 
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and the negatively charged carboxylate.  Comparatively, as seen in a trend between the 
binding constants, the anti tube bound the longer chains slightly better than the syn linked 
tube. In the case of both sensors, all analytes quenched the fluorescence upon their 
addition and displayed similar binding patterns. 
Table 4.1: Association constants for amide linked tube 
          Syn  Tube Anti Tube 
Guest Ka  (M-1) Isat/I0 Ka  (M-1) Isat/I0 
acetic acid - - - - 
butyric acid 17 1.25 18 0.92 
hexanoic acid 100 1.14 72 0.32 
octanoic acid 250 0.39 190 0.25 
decanoic acid 3,500 0.48 3,800 0.32 
dodecanoic acid 18,000 0.47 27,000 0.31 
trans-3-octenoic acid 92 0.61 110 0.26 
4-methyl-octanoic acid 71 1.05 200 0.32 
8-methyl-nonanoic acid 1,600 0.57 690 0.25 
cyclohexane carboxylic acid 470 7.1 100 0.8 
triethylene glycol 63 1.83 63 0.34 
1-heptanol 4,900 0.28 6,700 0.19 
cis-4-hepten-1-ol 1,200 1.32 5,200 0.58 
heptylamine 16,000 0.42 16,000 0.11 
 
 In conclusion, a sensor was established that could detect fatty acids in aqueous 
solution that provided a fluorescent response selective to the shape and length of the 
guest. It is well known that water can quench fluorescence70, and we would expect that 
expulsion of water from the cavity would increase the fluorescence upon binding. Given 
that this did not occur, the quenching effect of the guests left us with some questions and 
lead to the exploration of allyl linked molecular tubes.  
4.1.3 Allyl linked molecular tube 
We hypothesized that while the amide linker is much more rigid than the thioether 
and amine linkers, the amide linker may still may not be rigid enough to maintain an 
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open conformation and collapses in solution. Therefore, when it binds to the hydrophobic 
guests there is no water to expel from the cavity, giving rise to a quenched fluorescence. 
To confirm this hypothesis the allyl linked tube was synthesized as shown below.   
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Table 4.2: Binding constants of allyl linked tube 	
  Syn Tube   Anti Tube   
Guest Ka  (M-1) Isat/I0 Ka  (M-1) Isat/I0 
butyric acid - - - - 
hexanoic acid 800 1.54 - - 
octanoic acid 17,000 1.54 5,400 1.37 
decanoic acid 140,000 1.97 120,000 1.46 
dodecanoic acid 590,000 1.79 350,000 1.79 
4-methyoctanoic acid 5,200 2.02 5,800 1.44 
8-methylnonaoic acid 93,000 2.07 13,000 1.61 
1-heptanol 420,000 1.1 240,000 1.47 
heptylamine 2,000,000 0.63 8,200,000 1.25 
cis-4-hepten-1-ol 39,000 0.64 28,000 1.22 
trans-3-octenoic acid 1,300 0.61 7,200 0.61 
 
 
 The binding constants of the allyl linked tube are significantly higher than the 
amide linked tube. Specifically, for octanoic acid, the amide linked tube 24 and 25 has a 
Ka of ~ 200 M-1. For the allyl linked tube 32 Ka = 17,000 and 33 the Ka = 5,400. 
Furthermore, the allyl linked tube also displayed an increase in fluorescence upon 
binding to these lipids. Therefore, the allyl linked tube provides a “pre-organized” 
hydrophobic cavity providing a higher affinity and enables a “turn-on” response when 
binding to lipids. Furthermore, as was noted in previous studies, a preference for 
uncharged or positively charged species is maintained as in the case of heptylamine with 
a Ka of 8,200,000 M-1 for 33. The tubes were deemed unsuitable for binding alkenes. In 
conclusion, this study did prove that our hypothesis was correct.  
4.1.4 Tetraacid open tube 
Our group previously established selectivity for lipid chains with our allyl and amide 
linked tubes. While they demonstrated selectivity and affinity towards these lipids, they 
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presented some limitations: namely their relatively complicated synthesis and low overall 
yield. Additionally, the more lipid sensitive syn tube was synthetically accompanied by 
its anti isomer, therefore its maximum yield was only 50%. Thus a similar alternative was 
pursued.  
As we aimed to further these studies towards more biological lipids by modifying the 
tube with functional groups targeting the head groups of the lipids, we first needed to test 
the functionality and versatility of a more synthetically accessible scaffold. We planned 
to test this new scaffold towards the binding of hydrophobic amines, as heptylamine was 
shown to be the best binding analyte in our previous studies. This lead to the creation and 
publication of a sensor for the selective detection of hydrophobic amines in aqueous 
solution by Chun Ren114.  
This new sensor shown in Figure	 4.3 bears many changes. Instead of two 
naphthalene units being linked together, it retains the naphthalene core but possesses a 
carbazole unit connected to it by a one atom linker. This one atom linker reduces the 
rotational freedom, but still provides a snug fit for the alkane chain. The carbazole now 
acts the fluorophore, which is more red in the UV than the naphthalene and can easily be 
modified with functional groups to bind the headgroups of the different biological lipid 
targets. This tube now possesses an open cavity, which would accommodate branching 
and lipids of irregular shape, allowing the possible binding of biological compounds that 
possess multiple lipid chains.  
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Figure 4.3 First hydrophobic amine sensor by our group 
The synthesis of the sensor is shown in Scheme	 4.2. The sensor showed selectivity 
for long chain unbranched lipids; however, it was shown that it also tolerated branching 
in the case of binding pseudophedrine. Binding constants for some hydrophobic amines 
tested are shown with the corresponding structures in Figure	4.4.  
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Scheme 4.2: Synthesis of hydrophobic amine tube 
 
 
Figure 4.4 Binding constants for some hydrophobic amines with previous sensor114-115 
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 This sensor maintained the high binding affinity of the alkyl chains, 
demonstrating that the open tube concept would be successful providing a hydrophobic 
cavity sufficient to bind the alkyl chains. Given this success we planned to take this 
concept further towards lipid extraction. 
We wanted to test the ability of the amine sensor to extract dodecylamine from a 
vesicle. To accomplish this, the sensor needed to be manipulated to ensure the large 
hydrophobic pocket (Figure	 4.5) would not embed itself into the lipid bilayer. Therefore 
a new sensor needed to be designed.  
 
Figure 4.5: Hydrophobic/Hydrophilic portions of amine sensor 
To accomplish this we proposed the following structure in Figure	 4.6 . The 
installation of the two new carboxylate groups should prohibit the sensor from 
embedding itself into the lipid bilayer to due to the repulsive charge of the phosphate 
headgroups against the carboxylates at pH 7.4. 
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Figure 4.6: Initially designed sensor for lipid extraction 
 
4.2 Hexaacid open tube   
The previous tetra acid tube possessed ethyl ester groups until the final 
saponification step. This project encountered synthetic challenges due to solubility 
requiring a change to a hexyl ester. This required the synthesis of hexyl bromoacetate. 
The proposed synthesis of the hexa acid sensor Figure	4.6 is shown below. 
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Scheme 4.3: Hexyl bromoacetate synthesis 
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Scheme 4.4: Synthesis of hexyl dimer 
 
Scheme 4.5: Synthesis of hexyl/ethyl ester Carbazole 
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Scheme 4.6: Synthesis of hexyl/ethyl ester open tube 
 
Scheme 4.7: Saponification of hexyl/ethyl ester tube 
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While this sensor was potentially synthesized, the final step yielded a product that 
was unable to be isolated and characterized. During the course of the final reaction the 
product either appeared to fall out of solution or solidified into a gel-like solid in DMSO 
in the NMR tube. There has been a publication with a dicarboxylic acid carbazole 
substituted in the same positions as a Zn2+ coordination polymer116, thus it is possible a 
metal organic framework (MOF’s) could be a contributing factor. Therefore, other 
alternatives were pursued, such as the installation of a serine or alanine unit. Serine was 
attempted first as it was expected to make the final product more hydrophilic than 
alanine. 
4.3 Serine linked hexa-acid Open Tube 
      
Figure 4.7: Amino acid groups 
 
 Our desire was to install the amino acid groups by an amide bond formation 
reaction and therefore we needed carboxylic acid groups present on the carbazole. 
However, the final reductive cyclization step has been shown to fail in the presence of a 
carboxylic acid functional group and therefore an orthogonal protecting group was 
pursued that could be deprotected in the presence of the other esters. A trimethylsilylethyl 
(TMSE) group was chosen, which is cleaved by fluoride. This changed the synthesis only 
of the carbazole unit, requiring the synthesis of a new phenyl boronic acid, as one was not 
commercially available. A pinacol boronic acid was chosen, as it would be stable to be 
purified by column chromatography as opposed to its boronic acid counterpart. Further 
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synthesis was performed as before, with the exception of the Suzuki coupling (Scheme	4.8). The previous base for the Suzuki coupling was CsF. This base was changed to 
K3PO4 to prevent unwanted deprotection of the TMSE ester during the reaction. This did 
not have any effect on the yield of the reaction. 
 
Scheme 4.8: Synthesis of TMSE pinacol boronic acid 
 
Scheme 4.9: TMSE carbazole 
 
Scheme 4.10: TMSE Tube synthesis 
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Figure 4.8: Newly designed hydrophobic amine sensor 
The newly designed serine hexa acid open tube is shown in Figure	 4.8. We 
hypothesized it would make the sensor even more hydrophilic with the hydroxyl units. To 
synthesize this sensor, the TMSE tube was deprotected with TBAF and was subjected to 
an amide coupling reaction with L-serine methyl ester to form the diamide product 
(Scheme	 4.11). While the amide product has been identified by NMR and MS, the 
saponfied product was unable to be detected by NMR, LC-MS or direct infusion MS. The 
MS identification failure could be due to the fact that multiple ions are present, it has 
fragmentation patterns that are unable to be predicted, or it has unstable ionization 
pathways, or due to alternative reactivity. Also, it is possible under basic conditions the 
hydroxyl group of serine could attack the other amide and cleave it; a similar 
phenomenon was seen with a carbazole aldehyde tube reacting with methylamine in 
Chun Ren’s research.  
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Scheme 4.11: TMSE cleavage, amide bond formation, and saponification 
This final product displayed solubility in water. The carbazole fluorophore has an 
absorbance (Figure 4.9a) max of 315 nm and a fluorescence (Figure	 4.9b) emission max 
at 422 nm.  
 
Figure 4.9: Absorbance and fluorescence spectrum of serine amino acid sensor in buffer 
(25 mM HEPES, 120 mM NaCl; pH = 7.4), [58] = 10-5 M 
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4.4 Alanine linked hexa-acid open tube 
Since we were unable to fully characterize the final serine tube product by LC-MS or 
NMR, an alanine version of the tube was synthesized. The hypothesis was that the 
hydroxyl unit of the serine was the problem. For the alanine tube, a mass spectrometry hit 
was obtained both by ESI direct injection and LC-MS+ mode with a C4 column. NMR 
data was unable to be obtained, and therefore we are using LC-MS as our 
characterization technique. With this knowledge in mind we decided to use this sensor to 
test the hydrophobic amines on hand to determine how it responds to them and compare 
its reactivity to the previously synthesized half tube. 
 
Scheme 4.12: Synthesis of alanine tube 
 The alanine tube had similar characteristics to the serine tube. The absorption max 
was at 315 nm for the carbazole fluorophore, with excitation at 315 nm providing λmax of 
429 nm  (Figure	4.10). 
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Figure 4.10: Absorbance and fluorescence of sensor 60, 10 µM sensor in buffer (25 mM 
HEPES, 120 mM NaCl; pH = 7.4), [60] = 10-5 M 
The sensor was analyzed for its stability under successive scans and was found to 
only have a 3% decrease in fluorescence intensity after 15 successive scans (Figure	4.11). Therefore we expect it to be photo stable for our experiments.  
 
Figure 4.11: Sensor 60 stability scan, excitation 315 nm, 10 µM sensor in buffer (25 mM 
HEPES, 120 mM NaCl; pH = 7.4), [60] = 10-5 M 
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4.4.1 Free analyte titrations 
 
Titrations were then carried out to determine the difference between the alanine 
sensor and the tetra acid sensor previously synthesized by Chun. It was found that the 
sensor did not sufficiently bind to mono alkylamines, however, it did bind well to 
diamines and spermine. Upon binding to monoamines, the sensor appeared to oil or fall 
out of solution. While it was not visually seen in the cuvette, evidence that suggests this 
is provided by a change in the UV. An initial increase in absorption is seen with 
decylamine or dodecylamine at 315 nm, followed by a decrease in the absorption below 
initial levels. This phenomenon lead to the testing of many different amines including 
trimethylammonium species and two tailed species, as we believed the cavity was 
binding two amines to fall out of solution.   
 
Figure 4.12: UV titration of 60 in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); 
[60] = 2 µM. 
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Table	4.3:	Binding	studies	of	sensor	60	with	alkyl	amines 
Entry Guest Kd (M) Ka (M-1) Isat/I0 
1 1,7-diaminoheptane 2.75 E-4 3,600 0.177 
2 1,8-diaminooctane 8.25 E-5 12,100 0.379 
3 1,10-diaminodecane 1.32 E-5 76,000 0.313 
4 Spermine 1.52 E-5 66,000 0.182 
5 Spermidine 1.66 E-4 6,000 0.207 
6 Hexylamine 1.59 E-3 600 0.529 
7 Octylamine 4.52 E-4 2,200 0.447 
8 Decylamine 4.39 E-4 2,300 0.849 
9 Benzyl viologen 3.49 E-6 290,000 0.859 
 
 
 
Figure 4.13: Structures of the alkyl amines tested in binding studies 
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 Of the diamines tested (entries 1-3), 1,10-diaminodecane displayed the best 
binding, Figure	 4.14. 1,12-diaminododecane was not tested, as it did not dissolve 
completely in the sensor analyte solution. The diamines (entries 1-3) and monoamines 
(entries 6-8) tested displayed a decrease in the fluorescence. This decrease is due to 
photoinduced electron transfer (PET) from the amine, quenching the fluorophore 
fluorescence. Spermine, a polyamine with high positive charge, bound tightly due to 
electrostatic interactions, but with a fluorescence increase. The alkane portion 1,10-
diaminodecane binds well within the hydrophobic cavity, while the protonated amines 
extend out on either side and associate with the negatively charged carboxylate groups of 
the sensor. This association allows for both hydrophobic binding and charge-charge 
interactions.  
 
   
Figure 4.14: Fluorescence titration of sensor 60 with 1,10-diaminodecane in buffer (25 
mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence 
emission spectra as a function of added 1,10-diaminodecane, b) fit of titration data at λem 
= 429 nm to a single-site binding isotherm; R2 = 0.993; Kd = 1.32 E-5 M;  Ka = 76,000 
M-1. 
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Additional amines were tested to determine the extent of the hydrophobic amine 
binding. The next groups that were tested were 1˚ amines with two tails and trimethyl 
ammonium species of the mono amines. The trimethylammonium species were tested, as 
we believed the monoamines were binding two within the cavity and falling out of 
solution. The trimethylammonium group we believed would help to inhibit the binding of 
the second analyte.  
Octyl, decyl, and dodecyltrimethylammonium bromide have no lone pair to allow 
PET quenching, therefore the binding to the sensor provides a fluorescence increase. The 
analytes bound, however, they displayed significantly lower binding constants and did 
not display linear biding. Figure 4.16 shows the binding of octyltrimethylammonium 
bromide, where there is an initial binding event and plateau, followed by an increase in 
signal. This is similar to what was observed with dodecylamine. A similar phenomenon is 
observed with decyltrimethylammonium bromide and dodecyltrimethylammonium 
bromide. As expected, between 4-heyptylamine and 5-nonylamine, the longer chain 
amine provided a better binding constant. These two amines showed a linear response as 
opposed to the response seen with the monoamines, demonstrating that the cavity is 
potentially binding two lipid tails simultaneously.   
 
Figure 4.15: Structures of additional analytes tested 
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Figure 4.16: Fluorescence titration of sensor 60 with octyltrimethylammonium bromide 
in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) 
fluorescence emission spectra as a function of added octyltrimethylammonium bromide, 
b) fit of titration data at λem = 429 nm to a single-site binding isotherm; R2 = 0.974; Kd = 
1.05 E-3 M; Ka = 950 M-1. 
       
 
Figure 4.17: Fluorescence titration of sensor 60 with 5-nonylamine in buffer (25 mM 
HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission 
spectra as a function of added 5-nonylamine, b) fit of the titration data at λem = 429 nm to 
a single-site binding isotherm; R2 = 0.993; Kd = 5.64 E-4 M; Ka = 1,800 M-1. 
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Given that 1˚ amines with two tails appeared to bind to the sensor, we wanted to 
expand our experiments to additional amines with two tails, leading us to test 2˚ amines: 
diamylamine and dihexylamine (Figure	 4.18). These analytes retain a similar number of 
carbons of the previous analytes and therefore we expect them to display similar binding 
characteristics. Dihexylamine appeared to bind much better than the two tailed 1˚ amines, 
while diamylamine fit a binding isotherm poorly.  
 
 
Figure 4.18: Structures of 2˚ amines tested 
   
Figure 4.19: Fluorescence titration of sensor 60 with dihexylamine in buffer (25 mM 
HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission 
spectra as a function of added dihexylamine, b) fit of the titration data at λem = 429 nm to 
a single-site binding isotherm; R2 = 0.979; Kd = 2.17 E-5 M; Ka = 46,000 M-1. 
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A blue shift can be observed when binding to any of the aforementioned analytes. A 
few have a more pronounced blue shift than others, specifically the analytes that appeared 
to bind more tightly. Furthermore, spermine, spermidine, and the trimethylammonium 
bromide derivatives displayed a fluorescence increase upon binding. While the remaining 
analytes exhibited a decrease in fluorescence, the intensity of the decrease varied between 
the sets of analytes. The single chain monoamines appeared to quench the fluorescence 
more efficiently than the diamines. As our next set of studies would occur in vesicles at a 
much lower concentration, we explored an additional analyte that would potentially 
quench the fluorescence more significantly, benzyl viologen. 
  
 
Figure 4.20: Structure of benzyl viologen dibromide 
 Benzyl viologen is a hydrophobic water soluble molecule, which bound to the 
alanine hexaacid sensor remarkably well (Figure	 4.21). As expected, benzyl viologen 
quenched the fluorescence significantly, with a decrease of about 86%, while also 
binding with a Ka much higher than all previously tested analytes, Ka = 290,000 M-1.  
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Figure 4.21: Fluorescence titration of sensor 60 with benzyl viologen in buffer (25 mM 
HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission 
spectra as a function of added benzyl viologen, b) fit of the titration data at λem = 429 nm 
to a single-site binding isotherm; R2 = 0.999; Kd = 3.49 E-6 M; Ka = 290,000 M-1. 
With these free analyte tests completed we moved forward toward testing the ability of 
this sensor to extract the tested analytes from synthetically prepared vesicles.  
4.4.2 Vesicle Titrations 
Synthetic vesicles were prepared in our lab from either DMPC (phosphotidyl choline 
headgroup), DMPS (phosphotidylserine headgroup), or a 80:20 mixture of 
DMPS/DMPC.  The vesicles were extruded to create a uniform distribution of vesicles 
<200 nm in size. To account for the interaction of the sensor with the vesicle, titrations 
were carried out with analyte free vesicles to determine the affect of scattering on the 
vesicles. Our fluorescence instrument has a front face mode, which decreased the 
scattering effect.  
DMPC did not fit a binding isotherm, nor did it appear to have a trending effect on 
the fluorescence (Figure	 4.22). DMPS vesicles (100% DMPS), however, showed a small 
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decrease in fluorescence and fit a binding isotherm ((Figure	 4.23). As the fluorescence 
decreased, it is unlikely that the sensor is embedding into the membrane. DMPS is 
typically present on the inner leaflet of membranes and at around 20% in membranes, 
which would explain why the size of these vesicles was significantly smaller than the 
DMPC vesicles. This would create a vesicle that is significantly more curved, which 
could permit a closer interaction between the headgroup of the lipid and the sensor, 
allowing the amine to quench the fluorescence. DMPC/DMPS vesicles (80:20), also did 
not fit a binding isotherm and had no trending affect on the fluorescence (Figure	 4.24). 
Finally, DMPC vesicles were also tested with 10 mol% cholesterol, which exhibited no 
trending changes in the fluorescence and did not fit a binding isotherm (Figure	 4.25). 
Thus it seemed that the sensor had little interaction with the vesicles, based on the small 
changes in fluorescence. 
 
Figure 4.22: Fluorescence titration of sensor 60 with DMPC in buffer (25 mM HEPES, 
120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission spectra as 
a function of added DMPC. 
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(Figure 4.23: Fluorescence titration of sensor 60 with DMPS in buffer (25 mM HEPES, 
120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission spectra as 
a function of added DMPS, b) fit of the titration data at λem = 429 nm to a single-site 
binding isotherm; R2 = 0.966; Kd = 7.34 E-6 M; Ka = 136,000 M-1. 
 
 
Figure 4.24: Fluorescence titration of sensor 60 with DMPC/DMPS (80:20) in buffer (25 
mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence 
emission spectra as a function of added DMPC/DMPS (80:20). 
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Figure 4.25: Fluorescence titration of sensor 60 with DMPC vesicles with 10 mol% 
cholesterol in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 
nm; a) fluorescence emission spectra as a function of added DMPC vesicles with 10 
mol% cholesterol. 
The best binding free analyte that quenched the fluorescence of the sensor was 1,10-
diaminodecane and benzyl viologen. Therefore these analytes were explored in our 
vesicle titration studies. DMPC vesicles were prepared, however, 5 mol% of 1,10-
diaminodecane (or other tested analytes) was added during the drying or hydration step as 
indicated in the appendix procedures. The resulting vesicles were similar in size to their 
parent amine free vesicles. Titration of the 1,10-diaminodecane loaded vesicles displayed 
a fluorescence decrease and fit a single site binding isotherm (Figure	 4.26).  Assuming 
the amine is inside the bilayer of vesicle, the decrease in the fluorescence indicates that 
the sensor is indeed removing the amine from the vesicle. 
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Figure 4.26: Fluorescence titration of sensor 60 with DMPC vesicles with 5 mol% 1,10-
diaminodecane in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 
315 nm; a) fluorescence emission spectra as a function of added DMPC vesicles with 5 
mol% 1,10-diaminodecane, b) fit of the titration data at λem = 429 nm to a single-site 
binding isotherm; R2 = 0.986; Kd = 1.31 E-5 M; Ka = 77,000. 
The next test was to determine the effect of DMPS on the extraction process, thus the 
amine was loaded into the 80/20 DMPC/DMPS vesicles. We expected the DMPS to 
make the extraction of the amine more difficult, however, it did not appear to have a 
significant impact on the binding (Figure	 4.27). The binding constant and fluorescence 
intensity decrease was similar to the DMPC vesicles, indicating that the DMPS had no 
effect on the extraction process.  
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Figure 4.27: Fluorescence titration of sensor 60 with DMPC/DMPS (80:20) vesicles with 
5 mol% 1,10-diaminodecane in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 
2 µM, λex = 315 nm; a) fluorescence emission spectra as a function of added 
DMPC/DMPS (80:20) vesicles with 5 mol% 1,10-diaminodecane in buffer, b) fit of the 
titration data at λem = 429 nm to a single-site binding isotherm; R2 = 0.977; Kd = 1.35 E-5 
M; Ka = 74,000 M-1. 
We then wanted to determine how the presence of cholesterol within the vesicle 
would affect the extraction process. Therefore DMPC vesicles with 10 mol% of 
cholesterol in addition to the 5 mol% amine were made and titrated with the sensor. The 
result showed a decrease in the fluorescence and a fit to a binding isotherm. The presence 
of cholesterol within the vesicle appears to either facilitate the removal of the amine or 
helps to stabilize the vesicle, allowing the removal of the amine.  
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Figure 4.28: Fluorescence titration of sensor 60 with DMPC vesicles containing 10 
mol% cholesterol and 5 mol% 1,10-diaminodecane in buffer (25 mM HEPES, 120 mM 
NaCl; pH = 7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission spectra as a 
function of added DMPC vesicles containing 10 mol% cholesterol and 5 mol% 1,10-
diaminodecane, b) fit of the titration data at λem = 429 nm to a single-site binding 
isotherm; R2 = 0.992; Kd = 9.63 E-6 M; Ka = 104,000 M-1. 
Benzyl viologen, the other free analyte that bound tightly and quenched the 
fluorescence the most was also tested in vesicles. DMPC vesicles were prepared with the 
analyte present at 5 mol%. Titrations (Figure	 4.29) demonstrated this analyte was able to 
be extracted from the vesicle, fitting a one-site binding isotherm. The decrease in 
fluorescence was not as significant as in the free analyte, 73% vs. 86%. This decrease is 
far superior to the previous amine analytes, and demonstrates a hydrophobic molecule 
can be extracted from the bilayer of a membrane.  
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Figure 4.29: Fluorescence titration of alanine hexaacid with DMPC vesicles with 5 
mol% benzyl viologen in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, 
λex = 315 nm; a) fluorescence emission spectra as a function of added DMPC vesicles 
with 5 mol% benzyl viologen b) fit of the titration data at λem = 429 nm to a single-site 
binding isotherm; R2 = 0.999; Kd = 4.16 E-6 M; Ka = 241,000 M-1. 
Dihexylamine showed an initial binding towards a maxima, and then showed an 
increase in the fluorescence. The accompanying decrease in fluorescence was only about 
5%, with the increase returning the fluorescence to near its initial status. A similar 
observation was observed with octylamine vesicles. Both spectrums were still 
accompanied by a blue shift, as observed in all previous titrations.  
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Figure 4.30: Fluorescence titration of sensor 60 with DMPC vesicles with 5 mol% 
octylamine in buffer (25 mM HEPES, 120 mM NaCl; pH = 7.4); [60] = 2 µM, λex = 315 
nm; a) fluorescence emission spectra as a function of added DMPC vesicles with 5 mol% 
Octylamine, b) titration data at λem = 429 nm. 
Dodecyltrimethylammoniumbromide was also tested in vesicles. This analyte was 
expected to produce an increase in fluorescence on binding, as the amine cannot quench 
the fluorescence. A binding event and increase in fluorescence was observed along with 
another phenomena.  The binding isotherm appears to show an initial biding event, 
followed by a linear increase in the fluorescence (Figure	 4.31). While UV data was not 
obtained for this analyte, a similar observation was observed with the free analyte 
dodecylamine.  
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Figure 4.31: Fluorescence titration of sensor 62 with DMPC vesicles with 5 mol% 
dodecyltrimethylammonium bromide in buffer (25 mM HEPES, 120 mM NaCl; pH = 
7.4); [60] = 2 µM, λex = 315 nm; a) fluorescence emission spectra as a function of added 
DMPC vesicles with 5 mol% dodecyltrimethylammonium bromide, b) titration data at 
λem = 429. 
We decided to pursue a biological lipid, sphingosine, to more closely resemble a 
biological system. However, the analyte in vesicles did not fit a binding isotherm or show 
a trend in the fluorescence binding. Decylamine, dodecylamine, 1,8-diaminooctane, 5-
nonylamine and 4-heyptylamine were also tested in vesicles; however, they did not fit a 
binding isotherm nor did they have a significant effect on the fluorescence as represented 
with the other examined analytes.  
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Table 4.4: Binding constants of sensor 62 with vesicle/analyte systems 
Entry	 Guest	
phospholipid	
system	 Kd	(M)	
Ka	(M-
1)	
Isat/I
0	
1	 1,10-diaminodecane	 DMPC	
1.31	E-
5	 77,000	 0.25	
2	 1,10-diaminodecane	 DMPC/DMPS	
1.35	E-
5	 74,000	 0.27	
3	 1,10-diaminodecane	 DMPC/cholesterol	
9.63	E-
6	
104,00
0	 0.23	
4	 benzyl	viologen	 DMPC	
4.16	E-
6	
241,00
0	 0.73	
5	 octylamine	 DMPC	 -	 -	 -	
6	
dodecyltrimethylammonium	
bromide	 DMPC	 -	 -	 -	
7	 sphingosine	 DMPC	 -	 -	 -	
8	 decylamine	 DMPC	 -	 -	 -	
9	 dodecylamine	 DMPC	 -	 -	 -	
 
4.4.3 Future Work 
The fluorescent labeled amine lipids in Figure	 4.32 will be synthesized and titrations 
will be carried out with the alanine sensor in vesicles. If this proves successful, an 
experiment using dialysis membranes will be used to fully ascertain the capability of the 
sensor to extract these lipids, and ensure it is successfully happening.   
 
Figure 4.32: Fluorescent lipids 
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4.5 Conclusion We	 have	 synthesized	 an	 open	 tube	 alanine	 sensor	 that	 shows	 binding	 to	hydrophobic	amines	with	one	or	two	lipid	tails.	Furthermore,	this	sensor	has	proven	to	 be	 capable	 of	 extracting	 some	 of	 the	 selected	 amines	 from	 vesicles,	 without	embedding	 itself	 into	 the	 membrane.	 This	 indicates	 that	 the	 alanine	 amphiphilic	sensors	design	worked	as	expected.		
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Chapter 5 Molecular Tubes for the Detection of Glycolipids 
5.1 Molecular Tubes for the Sensing of Glycolipids 
Our group has long been interested in developing fluorescent sensors for biologically 
relevant lipids. One of these aims is to develop a sensor for glycolipids.  As discussed 
earlier, molecular recognition can use the process of both non-covalent and covalent 
interactions for the recognition of analytes. Glycolipids contain either a sugar or 
carbohydrates as the polar head group and a non-polar alkyl chain, and our sensor is 
designed to bind both groups. As mentioned earlier, phenylboronic acids are well known 
to bind to saccharides and this will be appended to the already designed molecular open 
tube for its detection, Figure	 5.1. The fluorine substituent is used to adjust the pKa of the 
phenylboronic acid (pKa = 8.8) towards the physiological range.  
 
Figure 5.1: Originally designed glycolipid sensor 
The original synthesis of the sensor began with an aldehyde-based carbazole with an 
ethyl ester (Scheme	 5.2). The aldehyde was to be reacted with an amine, to later install 
the phenylboronic acid to via an amide bond formation reaction with a carboxylic acid 
appended phenyl boronic acid. Earlier in our group we found that the reaction of the open 
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tube aldehyde with methyl amine caused an intramolecular reaction upon the first 
addition, creating a cyclic tube and only installing one amine (Scheme	 5.1). Furthermore, 
use of a boc protected amine lead to complicated mixtures of products upon the 
deprotection that were unable to be determined or separated. 
 
Scheme 5.1: Open aldehyde tube intramolecular reaction 
With this in mind we attempted an alternative approach to installing a protected 
amine using an F-moc derivative, using triethysilane (TES) as a hydride source, which 
also proved unsuccessful. During these attempts solubility was believed to be a problem 
for the process of the reaction, and thus the ethyl ester was replaced with a hexyl ester in 
the synthesis and was kept for future syntheses. 
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Scheme 5.2: Ethyl carbazole aldehyde Fmoc reactivity 	
Table 5.1: Ethyl carbazole aldehyde Fmoc reaction conditions 
 
Entry Reagents Equiv. 
Equiv. 
FMOC-
amide Solvent ˚C Result 
1 TFA, TES 
6.2, 
2.98 2.8 DCM/MeCN 80 
not enough 
product to 
identify 
2 TFA, TES 
7.15, 
10.7 10 DCM/MeCN r.t. recovered SM 
3 TFA, TES 
13.3, 
13.2 10.2 DCM/MeCN r.t. 
complex mixture, 
unable to separate  
4 TFA, TES 8, 8 5 DCM/MeCN r.t. returned SM 
5 TFA, TES 
13.4, 
13.3 10 DCM/MeCN r.t. 
incomplete rxn, 
unable to separate 
6 
Re2O7, 
TES .02, 1.2 1.2 DCM/MeCN r.t. no reaction 
7 
Re2O7, 
TES .02, 4.5 1.2 DCM/MeCN r.t. no reaction 
8 
Re2O7, 
TES 
.009, 
1.2 1.2 DCM 32 no reaction 
 
 
 
Scheme 5.3: Hexyl carbazole aldehyde Fmoc reactivity 
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Table 5.2: Hexyl carbazole aldehyde Fmoc reaction conditions 	
Entry Reagents Equiv. 
Equiv. 
FMOC-
amide Solvent ˚C Result 
1 
thiourea, 
Hantzsch 
ester .45, 1.16 1 DCM 35 SM returned 
2 
Re2O7, 
TES .015, 1.2 1.2 DCM r.t. SM returned 
3 
TFA, 
TES 5, 5 5 DCM/MeCN r.t. 
NMR (impure) & MS 
indicates product 
 
As the reaction appeared to work on the hexyl carbazole aldehyde an attempt was 
made to do the reaction on the aldehyde tube, which proved unsuccessful.  
 
Scheme 5.4: Aldehyde tube reaction with Fmoc 
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Table 5.3: Aldehyde tube reaction conditions 
Entry Reagents Equiv. 
Equiv. 
FMOC-
amide Solvent ˚C Result 
1 
TFA, 
TES 16, 16 16 DCM/MeCN r.t. returned SM 
2 
TFA, 
TES 35, 34 20 DCM/MeCN 40 complex mixture 
3 
TFA, 
TES 35, 35 10 DCM/MeCN r.t. recovered SM 
4 
TFA, 
TES 35, 34 20 DCM/MeCN r.t. recovered SM 
5 
TFA, 
TES 40, 40 30 DCE, MeCN 65 SM returned 
6 
TFA, 
TES 30, 30 10 DCE, MeCN 79 
no product upon 
deprotection 
7 
TFA, 
TES 40, 40 25 DCE, MeCN 80 SM returned 
8 
TFA, 
TES 30, 30 15 DCE, MeCN 80 SM returned 		 Because	 installing	 an	 amine	 to	 react	 with	 a	 carboxylic	 acid	 functionalized	phenylboronic	acid	was	proving	unsuccessful,	we	attempted	to	react	the	carbazole	aldehyde	 with	 an	 amine	 functionalized	 phenylboronic	 acid.	 This	 attempt	 also	proved	unsuccessful,	either	returning	starting	materials	or	reducing	the	aldehyde	to	the	alcohol.		
 
Scheme 5.5: Carbazole reductive amination with amino phenylboronic acid 		
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Table 5.4: Amino phenylboronic acid reductive amination reaction conditions 
 
Entry Reagents Equiv. 
Equiv. 
Amine Solvent ˚C Result 
1 NaBH3CN 1.1 1.1 DCE r.t. SM returned 
2 NaBH4 0.62 1.5 MeOH r.t. 
obtained alcohol and 
ester exchange 
3 NaBH(OAc)3 1.4 1 DCE r.t. SM returned 
4 AcOH  Cat.   
Tolulene, 
Ethanol reflux 
no product formation   NaBH4  1.2   THF r.t. 
5 
NaBH3CN, 
AcOH 
1.2, .5 
mL 1.3 
DCM, THF, 
EtOH 80 no product formation 
6 
NaBH3CN, 
AcOH 
1.1, .25 
mL 1 
THF, EtOH, 
DCE 66 alcohol formed 
 
Given that a reductive amination approach was not fruitful, the aldehyde group 
was replaced with a protected carboxylic acid group that could later be orthogonally 
deprotected to react with an amine for an amide bond formation reaction as was used 
previously with the amine sensor. This gave us 69 as a material for both sensors, which 
can then be reacted with an amino boronic acid to provide the tetra ester boronic acid, 
which can then be saponified to provide the final product.  
 
Scheme 5.6: Aminoboronic acid amide bond formation 
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Table 5.5: Aminoboronic acid amide bond reaction conditions and results 
Entry Reagents Equiv. Equiv. 
Amine 
Solvent ˚C Result 
1 Pybop, 
DIPEA 
1.2, 2.0 1.1 DMF r.t. Lost boron 
2 Pybop, 
DIPEA  
1.2, 2.0 1.1 DMF r.t. Lost boron 
 
 
 
Scheme 5.7: Fluoroaminoboronic acid amide bond formation 
Table 5.6: Fluoroaminoboronic acid amide bond reaction conditions and results 
 
Entry Reagents Equiv. Equiv.
amine 
Solvent ˚C Result 
1 EDC, HOBt, TEA 1.2 1.2, 
2.5 
1 DMF r.t. 67% HPLC yield 
2 EDC, HOBt, TEA 1.2, 1.2, 
3.5 
1 DMF r.t. 71% HPLC yield 
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Changing the methylaminomethylphenylboronic acid to a fluorine substituted 
aminomethylphenylboronic acid proved successful. While the above reaction worked, it 
did not work on the dicarboxylic acid tube. While the crude product from that reaction 
looked reasonable via 1H NMR,  LC-MS did not identify the product. Further 
saponification of the crude product yielded a product by 1H NMR that was unable to be 
determined, nor was LC-MS analysis successful. Later attempts to repeat the coupling 
reaction on the carbazole proved unsuccessful and therefore an alternative coupling 
reagent was pursued. 
 
Scheme 5.8: Fluoroaminoboronic acid amide bond formation with new reagent 
Table 5.7: Fluoroaminoboronic acid reaction conditions and results 	
Entry Reagents Equiv. Equiv. 
amine 
Solvent ˚C Result 
1 HATU  
DIPEA 
1.2 
3 
1.2 DMF r.t. 14% HPLC yield, 6% side 
product 
2 HATU 
DIPEA 
2 
5 
4 DMF r.t. 30% HPLC yield, 16% side 
product 
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The coupling reagent was changed to HATU and product formation was found, 
however, in low yield, with a side product. The first attempt gave 14% yield, with 6% 
side product by HPLC and the second attempt gave an increased yield in both product 
and side product. The side product was determined to have the boron replaced with an 
alcohol (Figure	 5.2), as no boron was present via 11B NMR, and this product was 
identified via mass spectroscopy. Further analysis of a previous mass spectrum with the 
EDC coupling reagent showed this product was also forming in those early reactions as 
well.  
 
Figure 5.2: Side product obtained from amide bond formation reactions with boronic 
acid 
 As an unprotected boronic acid was giving us problems in the amide bond 
formation, we decided to use a pinacol boronic acid in our synthesis, also allowing us to 
eliminate the HPLC purification.  
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Scheme 5.9: Pinacol boronic acid amide bond formation 
 
Table 5.8: Pinacol boronic acid amide bond reaction conditions and results 	
Entry Reagents Equiv. amine solvent ˚C Result 
1 
HATU 
DIPEA 
1.2 
3.5 2.0 DMF r.t. 43% yield 
2 
HATU 
DIPEA 
1.2 
3.5 2.0 DMF r.t. 25% yield 
3 
HATU 
DIPEA 
1.1 
3.5 2.0 DMF r.t. 38% yield 
 
The reaction also appeared to work, however, in low yield and the crude mass 
spec also indicated presence of the aforementioned alcohol product. Given the low yield, 
it would not be ideal to perform the reaction on the carboxylic acid tube, as the resulting 
product would have a yield below 16%. Therefore a more convergent approach was 
attempted, using the carbazole product to react with the dibromide (Figure	5.3).  
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Figure 5.3: Formation of pinacol tetraester tube 
 Reacting the carbazole phenyl boronic acid with the dibromide proved to be 
unsuccessful. LC-MS and MS analysis did not indicate any product formation, however it 
did indicate the presence of the carbazole starting material and the carbazole alcohol 
product.  
5.2 Future Work As	a	convergent	attempt	was	not	successful	in	synthesizing	the	pinacol	boronic	acid	 tube,	 we	 plan	 to	 pursue	 the	 reaction	 with	 (3-bromo-4-fluorophenyl)methanamine,	followed	by	a	Miyuara	Borylation	reaction	to	install	the	boronic	acid	or	pinacol	boronic	acid.	The	reaction	series	will	 first	be	tested	on	the	carbazole	acid	and	if	successful	will	then	be	carried	out	on	the	carboxylic	acid	tube.		
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Scheme 5.10: Miyaura borylation approach for carbazole acid 
	
Scheme 5.11: Miyaura borylation approach for tube diacid 
If	 	 the	Miyaura	 approach	proves	 successful,	 the	 resulting	pinacol	 boronic	 acid	tube	product	will	be	saponified	(Scheme	5.12)	to	obtain	the	 final	 tetraacid	pinacol	
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boronic	 acid	 product.	 This	 product	 will	 then	 be	 used	 for	 the	 titrations	 of	 the	glycolipids	 (Figure	 5.4)	 both	 as	 free	 analytes	 and	 in	 phospholipid	 vesicles.	 If	 the	titrations	prove	successful,	 the	 sensor	will	 then	be	 tested	 for	 the	ability	 to	extract	Forssmann’s	antigen	from	sheep	blood.		
	
Scheme 5.12: Pinacol boronic acid tube saponification 
 
 
Figure 5.4: Glycolipids to be tested 	 		
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Chapter 6 Conclusions 	
In the course of this project, we have accomplished the ability to bind to hydrophobic 
lipid chains in aqueous environments. The initial goal of our project was to create a 
fluorescent sensor that was selective towards hydrophobic tails. Our desire was to apply 
this sensor for fluorescent sensing of biologically relevant lipids. This would be 
accomplished by attaching a head-group recognition site the sensor, providing two 
interaction sites: the hydrophobic cavity and the head-group binding site. To bind to these 
lipids it would also be necessary to design the sensor have a hydrophobic cavity, yet not 
embed into membranes. If successful, such a sensor could have many potential 
applications in biological systems upon further modifications.   
Sensor 24/25 and 32/33 provided a large hydrophobic cavity that encapsulated a 
hydrophobic guest. They bound better to longer chain guests, however, they were unable 
to tolerate branching or alkene chains. The amide 24/25 sensor was believed to collapse 
in solution and bound weaker than 32/33, which was much more rigid and remained open 
in solution. The Ka for the allyl tube 32/33 reached 106 M-1 for some analytes and higher 
for heptylamine. These binding constants were within what we expected the 
physiological range to be for some of our biological analytes such as glycolipids. While 
these sensors displayed good properties, our group wanted a sensor that was easier to 
synthesize that could bind to two tails. This led us to the design of our next sensor.  
The tetraacid sensor was designed similar to the open tube sensor bearing some 
changes. Instead of linking to naphthalene units together by a bridge, which would create 
a closed tube, we modified the original sensor to attach a carbazole unit to the 
naphthalene core by a one-atom linker. This one atom connection allowed for some 
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flexibility without allowing the new “open” tube to collapse on itself. The carbazole is 
easy to synthesize, contributing to the hydrophobic nature of the cavity and still allowing 
the binding of the intended guests. The synthesis of the new sensor is short, allowing 
modifications to attach a head-group binding unit for the different intended biological 
analytes. It remains fluorescent in the UV region but slightly redder than the naphthalene. 
This new sensor remained water-soluble and the binding studies showed that it bound to 
long hydrophobic chains of 10 or 12 carbon amines with Ka on the order of 106 M-1 as 
well, and accommodated alkenes and branching. While the sensor was easier to 
synthesize and tolerated branching, which could permit binding a second chain, the 
hydrophobic nature of the sensor would allow it to embed into membranes. This led to 
the design of a new sensor.  
Sensor 60 was designed to ensure it would not embed into a membrane by appending 
the hydrophobic end of the tetraacid sensor with charged groups. Sensor 60 was 
fluorescent with a maximum of 429 nm and an absorption maximum of 315 nm. The 
sensor bound to diamines best, with the longer chain 1,10-diamiondecane binding better 
than shorter chains, all providing a PET quenching effect with Ka’s near 106 M-1.  
Amines tested with the previous tetra acid sensor such as dodecylamine did not fit a 
binding isotherm, but the PET quenching effect was present providing a fluorescence 
decrease. The binding isotherm showed an initial plateau, followed by a linear increase 
afterwards. The UV showed an increase in absorption, which was followed by a decrease 
below the initial free sensor maximum. This we attributed to the sensor analyte complex 
falling out of solution, most likely due to the binding of two analytes; this would create a 
large carbon content in water that could make it oil out of solution. Decylamine provided 
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a similar response in the biding isotherm and fluorescence changes. The shorter amines 
did bind, although, binding constants were lower than with the tetraacid sensor.  
Trimethyl ammonium derivatives were tested to determine if they would inhibit the 
binding of a second analyte. The fluorescence response was an increase instead of a 
decrease due to the absence of a lone pair for quenching, however, the binding isotherm 
still showed a linear response. The response was delayed, with the sensor being able to 
bind more analyte before the linear response was triggered. The UV however, showed 
little change with the carbazole absorption, but showed an increase with the naphthalene 
absorption units. While many of the other analytes provided an increase in absorption in 
the UV, the trimethylammonium derivatives may not have successfully repelled a second 
chain from entering the cavity.  
We tested two chain amines to determine if two chains could bind successfully. This 
led to test dihexylamine, 4-heptylamine and 5-nonylamine. These all provided binding 
responses that fit a binding isotherm, showing a fluorescence decrease. Dihexylamine 
provided the largest binding constant of the three, as would be expected by its longer 
chain. The shorter chains still bound less poorly, as was observed with previously 
analytes. This result provides evidence that the hydrophobic cavity is the main driving 
force for the binding, followed by the association of the negatively charged carboxylates 
with the protonated amine.  
The previously tested analytes only quenched the fluorescence about 30%, so we 
decided to test benzyl viologen, a known quencher due to its electron poor nature, to 
achieve a larger quenching effect. It was shown to bind the best, with the Ka reaching 106 
M and quenching near 90%.  
	 99	
These analytes were then tested for their response in vesicles. Sensor 60 was then 
tested with vesicles to ensure it would not embed into membranes. The response in 
fluorescence when titration with DMPC, DMPC/DMPS or 10 mol% cholesterol in 
DMPC showed little change in fluorescence which did not fit a binding isotherm, 
indicating to us that we see no interaction between the sensor and the vesicles. This 
indicates the sensor is not embedding into the membrane and would be applicable for use 
in titrations.  
The vesicles were then loaded with 5 mol% analyte to determine if the sensor was 
able to remove them from the vesicles. 1,10-diaminodecane and benzyl viologen 
provided positive responses, which could be attributed to the fact that they had high 
binding constants. The fluorescence response was smaller due to the lower concentration 
of analyte, but binding constants were still similar to the free analyte titration quantities. 
Incorporation of DMPS to create an anionic vesicle appeared to have no affect on the 
ability to remove the amine analyte, while cholesterol enhanced the binding constant 
indicating it helps to facilitate the removal and binding in some way. 
While it was already known that methyl cyclodextrin can remove cholesterol from 
membranes, there is little on removing biological lipids. This work has shown that it is 
possible to remove hydrophobic amine analytes from synthetically prepared lipids which 
have been varied in their content. The  process for how this happens is unknown. It is 
believed that the initial interaction happens between the charged carboxylates and the 
amine. 
As we have shown the ability to extract these amines from vesicles with sensor 60, 
the goal is to now modify the sensor to target binding biological lipids. This will be 
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accomplished by installing phenylboronic acid units on the carbazole in place of the 
alanine to bind to glycolipids. The glycolipid sensor will be tested with free analytes and 
in vesicles to determine its response and ability to remove biological lipids from 
membranes. If this proves successful, we will test Forssmann’s antigen to determine if it 
is possible to bind to blood group antigens.   
If successful, these sensors can be applied to human biological systems. As discussed 
earlier in Chapter 3, glycolipids are part of the ABO blood group antigens, located on the 
surface of the red blood cells (Figure 6.1). Patients with type A have antibodies for type 
B, and patients with type B have antibodies for type A, while those with type O have 
antibodies for both. Because of these antibodies, transfusion of red cells containing A or 
B antigens to a patient who has the corresponding antibodies results in a hemolytic event. 
The ability to remove these antigens from the red blood cells of a donors blood would 
allow the blood to be transfused without a hemolytic event occurring. This would be 
incredibly beneficial to patients who have rare blood types, or when disasters occur 
creating a shortage in the blood supply.  
 
Figure 6.1: ABO blood antigen structure 
Lipid storage diseases such as Gaucher’s disease present another application of 
this work. As mentioned in Chapter 3, for patients diagnosed with Gaucher’s 
Disease, the body lacks a specific enzyme, ß-glucoside, which is important for the 
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digestive function of the glycolipids located in tissue macrophages. This sensor could 
potentially be applied as a treatment option for patients who suffer from this disease, 
as it could remove the glycolipids and redistribute them in the body. However, to 
accomplish this the sensor would require modifications to allow it to be delivered 
inside the cell, as the disorder is an intracellular process. 
The ability to remove these lipids is within reach, as our work with the alanine 
hexa acid sensor has demonstrated our capability to remove hydrophobic amines 
from synthetically prepared vesicles. Headgroup modification should permit 
extraction of the glycolipid. 														
	 102	
Appendix 
Experimental Procedures and Characterization Data 
 
Instrumentation 
Absorption spectra were recorded on an Agilent Cary 100 UV/Vis spectrophotometer at 
25˚C. Fluorescence spectra were recorded on a Horiba Fluorolog-3 spectrofluorometer at 
25˚C. NMR spectra were recorded on a Bruker Avance III 500, Bruker Avance III 600, 
Bruker DRX 300, or Bruker AVII+ 300.  Dynamic Light Scattering measurements were 
performed on a Protein Solutions DynaPro99 MSTC Dynamic Light Scattering 
Instrument with temperature control. HPLC purifications were performed using Waters 
2545 Quaternary Gradient Pump, 2998 photodiode arrary detector, and fraction collector, 
with helium sparge in solvents from Sigma Aldrich; using a C18 guard column and 
19x250 mm XBridge OBD 5µm C18 column. 
Sample Preparation: Hydrophobic Amine Sensors 
Solutions for UV/Vis and fluorescence spectroscopy experiments were prepared from a 
.367 mg mL-1 sensor stock solution in water, which was diluted with buffer (20 mM 
HEPES, 100 mM NaCl, pH 7.4) until a 10 µM or 2 µM sensor solution was obtained. 
Analytes were measured and diluted to volume with the buffered sensor solution to keep 
the sensor concentration constant throughout the course of the titrations. Some analytes 
required heating of the solution to dissolve into solution. 
Sample Preparation: Phospholipid Vesicles 
DMPC (12.5 mg in CHCl3) or a 80:20 mixture of DMPC/DMPS purchased from Avanti 
Polar Lipids was dried in a test tube under N2 (g) and placed under vacuum in a 
desiccator to continue drying overnight. The lipids were then hydrated with 0.55 mL 
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phosphate buffer (20 mM Na2HPO4, 5mM NaCl, pH 7.4). The test tube was placed in a 
heated bath at a temperature above the phase transition temperature of the lipid,  40-50˚C 
and sonicated for approximately one hour. The mixture was then drawn up in a syringe 
and extruded with a Lipofast Extruder (purchased from Avanti Polar Lipids) using a 
0.200 µm polycarbonate membrane. The vesicles were diluted with phosphate buffer to 
be measured using a DLS and stored in the refrigerator until use.  
 
Sample Preparation: Hydrophobic Amine Containing Vesicles 
For liquid amines: 
DMPC (12.5 mg in CHCl3) or a 80:20 mixture of DMPC/DMPS purchased from Avanti 
Polar Lipids was dried in a test tube under N2 (g) and placed under vacuum in a 
desiccator to continue drying overnight. The lipids were then hydrated by adding 0.55 
mL phosphate buffer (20 mM Na2HPO4, 5mM NaCl, pH 7.4), and then the appropriate 
µL amount of amine. The test tube was placed in a heated bath at a temperature above the 
phase transition temperature of the lipid,  40-50˚C, and sonicated for approximately one 
hour. The mixture was then drawn up in a syringe and extruded with a Lipofast Extruder 
(purchased from Avanti Polar Lipids) using a 0.200 µm polycarbonate membrane.. The 
vesicles were diluted with phosphate buffer to be measured using a DLS and stored in the 
refrigerator until use.  
 
For solid amines: 
A concentrate stock solution of the amine was prepared in ethanol or chloroform of 
roughly 40 mg/mL. DMPC or DMPC/DMPS was added to a test tube and 5 mol% of the 
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amine was added. The resulting solution was dried in a test tube under N2 (g) and placed 
under vacuum in a desiccator to continue drying overnight. The lipids were then hydrated 
with 0.55 mL phosphate buffer (20 mM Na2HPO4, 5mM NaCl, pH 7.4). The test tube 
was placed in a heated bath at a temperature above the phase transition temperature of the 
lipid,  40-50˚C and sonicated for approximately one hour. The mixture was then drawn 
up in a syringe and extruded with a Lipofast Extruder (purchased from Avanti Polar 
Lipids) using a 0.200 µm polycarbonate membrane. The vesicles were diluted with 
phosphate buffer to be measured using a DLS and stored in the refrigerator until use. 
 
Binding Constant Calculations 
The concentration of analyte was plotted against the fluorescence intensity and fit to a 
one-site binding isotherm using PRISM. 
 
Synthetic Procedures 
General Methods 
All reactions were carried out in oven-dried glassware under N2 (g) atmosphere. 
Tetrahydrofuran and diethyl ether were distilled from sodium benzophenone ketyl. 
Dichloromethane, toluene, triethylamine, and acetonitrile were distilled from CaH2. NMR 
spectra were recorded on a Bruker Avance III 500, Bruker Avance III 600, Bruker DRX 
300, or Bruker AVII+ 300. IR spectra were recorded on a Nexus 670 FT-IR E.S.P. High 
resolution mass spectra (HRMS) were carried out by a Bruker Apex-Qe FTMS at the Old 
Dominion University in Norfolk, Va or Thermo Scientific LTQ Orbitrap XL FTMS at 
Universtiy of Missouri –Columbia.  
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Materials 
All Chemicals were obtained from Sigma Aldrich, Fisher Scientific, Combi-Blocks, TCI 
America, Acros Organics, Alfa Aesar or Avanti Polar Lipids and were used without any 
further purification. Flash chromatography was performed with 60Å 40-63µm silica gel 
or 60Å 40-75 µm premium Rf silica gel (for molecules ≥1000 g/mol) from Sorbent 
Technologies.  
 
Vesicle Preparation 
DMPC vesicles were prepared by adding 0.5 mL DMPC (Avanti Polar Lipids, 25 
mg/ML, in CHCl3), and the chloroform was evaporated over a stream of nitrogen. The 
test tube was then placed under vacuum in a desiccator overnight. 0.55 mL phosphate 
buffer (20 mM phosphate, 5 mM NaCl, pH 7.4) was added to the test tube and it was then 
sonicated in a heated bath (50˚C) for one hour. The resulting milky solution was then 
drawn into a 1000 µL syringe and extruded through a 0.200 µM membrane using an 
extruder (Avanti polar lipids) on a hot plate, passing through 21 times. The final solution 
was then diluted to a total volume of 6 mL with HEPES buffer (25 mM HEPES, 120 mM 
NaCl, pH 7.4) to obtain a final vesicle solution used for titrations. The resulting solution 
was then measured by DLS to obtain the size of vesicles, measuring three times and 
taking an average: 173 nm.   
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hexyl 2-bromoacetate 39: Hexanol (13.75 mL, 115 mmol), TEA (16.7 mL, 136 mmol) 
and DCM (200 mL) were all added to a round bottom flask and chilled to -78˚C. 
Bromoacetylbromide 38 (10 mL, 115 mmol) was added via syringe to the chilled 
solution, stirring for three hours at -78˚C. The reaction quenched by the addition of water 
(100 mL) and extracted with DCM (3 x 100 mL). The organic layer was washed with 
water (3 x 100 mL), NH4Cl (3 x 100 mL), NaHCO3 (3 x 100 mL) and brine (3 x 100 
mL). The resulting organic layer was then dried with MgSO4, filtered and concentrated to 
give the product as a clear yellow liquid (21.1 g, 101 mmol, 88%). 1H NMR (500 MHz, 
CDCl3) δ 4.17 (t, 2H, J = 6.75 Hz), 3.83 (s, 2H), 1.66 (quin, 2H, J = 7.1 Hz), ~ 1.4 – 1.26 
(m, 6H), 0.89 (t, 3H, J = 7.02 Hz); 13C NMR  (126 MHz, CDCl3) δ 167.47, 66.61, 31.48, 
28.51, 26.08, 25.55, 22.63, 14.11; IR (neat, cm-1) 2956, 2921, 2856, 1736, 1468, 1275, 
1164, 1106, 983; HRMS for (C8H15BrO2)Na+  calculatd: 245.014763. Found: 
245.014906.  
O
OBrTEA, DCM, -78˚C
55%
HO
O
BrBr
38 39
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Hexyl 2-((6-hydroxynaphthalen-2-yl)oxy)acetate 40: 2,6-dihydroxynaphthalene (14.8 
g, 92.41 mmol) was dissolved in 430 mL of DMF. To the resulting solution sodium 
hydride-60% in mineral oil (3.71 g, 93.11 mmol) was slowly added. The solution was 
stirred for five minutes, followed by the addition of hexyl 2-bromoacetate 39 (12.6 mL, 
71.08 mmol). The resulting solution was stirred for 22 hours and then concentrated to 
give a crude solid. To the solid was added 10% HCl until no bubbles appeared, and the 
product was then extracted with DCM (3 x 200 mL), filtered, and concentrated. The 
crude product was purified by flash SiO2 chromatography with DCM to give the product 
as a tan solid (9.495 g, 31.4 mmol, 42%) (mp 83-86 °C). 1H NMR (300 MHz, CDCl3) δ 
7.47-7.55 (m, 2H), 7.14 (dd, 1H, J = 2.4, 9.0 Hz), 7.04-7.08 (m, 2H), 7.00 (d, 1H, J = 2.4 
Hz), 5.93 (s, 1H), 4.72 (s, 2H), 4.23 (t, 2H, J = 6.8 Hz), 1.60-1.69 (m, 2H), 1.24-1.35 (m, 
6H), 0.85 (t, 3H, J = 6.4 Hz); 13C NMR (75 MHz, CDCl3) δ 169.7, 154.1, 152.4, 130.4, 
129.2, 128.4, 128.1, 119.0, 118.4, 109.7, 107.4, 65.7, 65.5, 31.3, 28.5, 25.4, 22.5, 13.9; 
IR (neat, cm−1) 3407, 2954, 2925, 2852, 1736, 1605, 1511, 1393, 1213, 1111, 1066, 850; 
HRMS calculated for (C18H22O4)Na+ (M + Na)+: 325.14103. Found: 325.14111.  
O
OBr
HO
OH
NaH, DMF, 12 hr, 42% HO
O O
O
18 40
39
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dihexyl-2,2'-((16H-8,16-methanodinaphtho[2,1-d:1',2'-g][1,3]dioxocine-3,13-
diyl)bis(oxy))diacetate 41: To a solution of 40 (1.23 g, 3.89 mmol) in DCM (4 mL) and 
CH3NO2 (10 mL) was added TFA (4 mL). 1,1,3,3-tetramethoxypropane (.383 mL, 2.83 
mmol) was dropwise via syringe over two hours. The reaction was continued stirring for 
24 hours. The reaction was then concentrated, followed by the addition of 50 mL sat. 
NaHCO3, and the product was extracted with DCM (3 x 100 mL). The resulting organic 
layer was dried with Na2SO4, filtered, and concentrated. The crude product was subjected 
to flash SiO2 chromatography (0-2% Et2O/DCM) to give the product was a yellow 
oil/solid (.9891 g, 1.54 mmol, 79%) (mp 85 °C). 1H NMR (300 MHz, CDCl3) δ 8.40 (d, 
2H, J = 9.3), 7.39 (d, 2H, J = 8.7 Hz), 7.28 (dd, 2H, J = 2.7, 9.3 Hz), 7.08 (d, 2H, J = 9.0 
Hz), 6.95 (d, 2H, J = 2.7 Hz), 6.19 (s, 1H), 5.15 (s, 1H), 4.64 (s, 4H), 4.17 (t, 4H, J = 6.6 
Hz), 2.31 (s, 2H), 1.56-1.77 (m, 4H), 1.20-1.28 (m, 12H), .79-.88 (m, 6H); 13C NMR (75 
MHz, CDCl3) δ 169.0, 154.0, 148.9, 130.4, 127.3, 126.8, 124.4, 119.0, 118.7, 118.4, 
108.6, 91.4, 65.5, 65.4, 31.3, 28.5, 26.7, 25.4, 22.8, 22.4, 13.9; IR (neat, cm−1) 2958, 
2929, 2868,1753, 1671, 1626, 1454, 1172; HRMS  calculated for (C39H44O8)Na+ (M + 
Na)+:663.29294. Found: 663.29210.  
 
HO
O O
O
DCM, TFA
CH3NO2, 4 hr
    74%
O
O
O
O
O
O O
O
O
O O
O
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hexyl-2-((4,12-diformyl-13-(2-oxo-2-(pentyloxy)ethoxy)-16H-8,16-
methanodinaphtho[2,1-d:1',2'-g][1,3]dioxocin-3-yl)oxy)acetate 42: To a solution of 41 
(2.7 g, 4.22 mmol) in DCM (42 mL) at 0˚C was added TiCl4 – 1 M in DCM (16.9 mL, 
16.9 mmol). To the resulting solution alpha,alpha-dichloromethyl methyl ether (1.5 mL, 
16.88 mmol) was added and continued stirring for one hour at 0˚C, after which the 
solution was slowly raised to room temperature and stirred another three hours. The 
reaction was then quenched with NaHCO3 and the product was extracted with DCM ( 3 x 
100 mL) and concentrated. The crude product was then purified by flash SiO2 
chromatography (0-10% Et2O/DCM) to give the product as a yellow solid (2.2 g, 3.159 
mmol, 75%) (decomp 102 °C). 1H NMR (300 MHz, CDCl3) δ 10.84 (s, 2H), 9.03 (d, 2H, 
J = 9.6 Hz), 8.57 (d, 2H, J = 9.6 Hz), 7.25 (d, 2H, J = 8.4 Hz), 7.16 (d, 2H, J = 9.6 Hz), 
6.22 (s, 1H), 5.14 (s, 1H), 4.79 (s, 4H), 4.17 (t, 4H, J = 6.9 Hz), 2.37 (s, 2H), 1.55-1.64 
(m, 4H), 1.18-1.27 (m, 12H), .79-.83 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 191.9, 
168.3, 160.0, 149.5, 130.6, 127.6, 126.7, 125.5, 122.0, 118.4, 113.5, 91.1, 66.4, 65.8, 
31.2, 28.4, 26.6, 25.4, 22.7, 22.4, 13.9; IR (neat, cm−1) 2958, 2929, 2860, 1748, 1675, 
1589, 1524, 1385, 1201, 1054, 907, 817; HRMS calculated for (C41H44O10)Na+ (M + 
Na)+: 719.28267. Found: 719.28190. 
O
O O
O
O
O O
O
Cl
Cl
O
TiCl4, DCM  
0˚C 1.5 hrs
0˚C - r.t. 3 hrs
75%
O
O O
O
O
O O
O
H
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dihexyl-2,2'-((4,12-bis(hydroxymethyl)-16H-8,16-methanodinaphtho[2,1-d:1',2'-
g][1,3]dioxocine-3,13-diyl)bis(oxy))diacetate 43: A solution of 42 (570 mg, 0.819 
mmol) in THF (13 mL) and hexanol (10 mL)  was chilled to 0˚C. NaBH4 (89.6 mg, 2.37 
mmol) was added and stirring was continued for 40 minutes. The reaction was quenched 
with the addition of cold NH4Cl and extracted with DCM (3 x 100 mL). The resulting 
organic layer was dried with Na2SO4 and concentrated. The crude product was subjected 
to flash SiO2 chromatography (0-30% Et2O/DCM) to yield the product as a light yellow 
oil (461 mg, .658 mmol, 80%) 1H NMR (300 MHz, CDCl3) δ 8.49 (d, 2H, J = 9.3 Hz), 
7.99 (d, 2H, J = 9.2 Hz), 7.22-7.26 (m, 4H), 6.27 (s, 1H), 5.28 (s, 1H), 5.10-5.15 (m, 4H), 
4.81 (d, 4H, J = 4.8 Hz), 4.14 (t, 4H, J = 6.8 Hz), 2.43 (s, 2H), 1.56-1.60 (m, 4H), 1.24 
(s, 12H), 0.82-0.85 (m, 6H); IR (neat, cm-1) 3440, 2954, 2925, 2848, 1744, 1593, 1520, 
1401, 1197, 1103, 1062; HRMS calculated for (C41H48O10)Na+ (M + Na)+: 723.31397. 
Found: 723.31323. 
 
 
 
 
O
O O
O
O
O O
O
H
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O
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    80%
O
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dihexyl-2,2'-((4,12-bis(bromomethyl)-16H-8,16-methanodinaphtho[2,1-d:1',2'-
g][1,3]dioxocine-3,13-diyl)bis(oxy))diacetate 44: To a solution of 43 (1.547 g, 2.21 
mmol) in DCM (20 mL) was added PBr3 (575 µL, 6.05 mmol). The resulting solution 
was stirred for 14 hours followed by quenching with NaHCO3. The crude was extracted 
with DCM (3 x 150 mL), dried over Na2SO4, filtered and concentrated to give the 
product as a crystalline brown solid (1.8 g, 2.18 mmol, 99%) (mp 62 °C). 1H NMR (300 
MHz, CDCl3) δ 8.49 (d, 2H, J = 9.6 Hz), 7.85 (d, 2H, J = 9.3 Hz), 7.30 (d, 2H, J = 9.6 
Hz), 7.19 (d, 2H, J = 9.3 Hz), 6.28 (s, 1H), 5.26 (s, 1H), 5.06 (dd, 4H, J = 10.2, 27.2 Hz), 
4.82 (s, 4H), 4.19 (t, 4H, J = 6.6 Hz), 2.42 (s, 2H), 1.57-1.64 (m, 4H), 1.20-1.25 (m, 
12H), 0.80-0.84 (m, 6H); 13C NMR (75 MHz, CDCl3) δ 169.0, 151.8, 149.4, 128.5, 
127.4, 125.1, 123.5, 121.0, 120.0, 118.9, 114.4, 91.3, 66.9, 65.6, 31.3, 28.5, 26.8, 25.5, 
24.7, 23.0, 22.5, 13.9; IR (neat, cm−1) 3428, 2958, 2921, 2852, 1753, 1638, 1593, 1201, 
1074; HRMS calculated for (C41H46Br2O8)Na+ (M + Na)+: 847.14517. Found: 
847.14414. 
 
 
 
O
O O
O
O
O O
O
Br
Br
O
O O
O
O
O O
O
HO
HO
 PBr3
DCM
 14 hr, 99%
43 44
	 117	
 
 
	 118	
 
2-(trimethylsilyl)ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 52: A 
solution of 4-carboxyphenylboronic acid pinacol ester (3.02 g, 12.17 mmol), DMAP (320 
mg, 2.62 mmol) and EDC (4.7 g, 24.52 mmol) in DCM (40 mL) was chilled to 0˚C and 
stirred for 10 minutes. 2-(trimethylsilyl)ethan-1-ol (2.0 mL, 13.95 mmol) was added and 
the resulting mixture was stirred for 10 minutes, and then raised to room temperature and 
continued stirring for 16 hours. The reaction was concentrated and quenched by the 
addition of water, followed by an extraction with DCM (3 x 150 mL) and concentrated. 
The crude product was purified by flash SiO2 (DCM) to get the product as a white solid 
(2.805 g, 8.06 mmol, 67%) (mp 81 ˚C). 1H NMR (500 MHz, CDCl3) δ 8.01 (d, 2H, J = 
8.3 Hz), 7.86 (d, 2H, J = 8.25 Hz), 4.42 (2H, m), 1.35 (s, 12H), 1.14 (2H, m), .077 (s, 
9H); 13C NMR (126 MHz, CDCl3) δ 166.76, 134.69, 132.82, 128.49, 84.11, 63.27, 24.85, 
17.37, -1.47; 11B NMR (96 MHz, CDCl3) δ 30.36; IR (neat, cm−1) 2977, 2954, 1705, 
1498, 1391, 1364, 1272, 1107, 1016; HRMS calculated for (C18H29O4BSi)Na+ (M + 
Na)+: 370.18567. Found: 370.18566. 
 
 
 
 
 
B
OH
O
Me3Si
OH
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hexyl 2-(4-chloro-3-nitrophenoxy)acetate 46: To a solution of 4-chloro-3-nitrophenol 
(1.00 g, 5.76 mmol) in DMF (50 mL) was added K2CO3 (0.993 g, 7.2 mmol) and stirred 
for 10 minutes. To the resulting red solution hexyl 2-bromoacetate 40 (1.28 mL, 7.2 
mmol) was added via syringe and continued stirring for 14 hours. The reaction was 
concentrated to give crude and quenched by the addition of 10 mL 10% HCl. The product 
was extracted with DCM (3 x 70 mL) and concentrated to give crude solid. The product 
was purified via flash SiO2 (50-75% DCM/hexane) to give the product as a clear yellow 
oil (1.751 g, 5.55 mmol, 97%) 1H NMR (300 MHz, CDCl3) δ 7.45 (d, 1H, J = 9.0 Hz), 
7.40 (d, 1H, J = 3.0 Hz), 7.10 (dd, 1H, J = 3.0, 9.0 Hz), 4.68 (s, 2H), 4.21 (t, 2H, J = 6.8 
Hz), 1.61-1.70 (m, 2H), 1.29-1.33 (m, 6H), 0.90 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 
167.7, 156.6, 148.0, 132.5, 120.3, 119.3, 111.5, 65.9, 65.6, 31.2, 28.4, 25.4, 22.4, 13.9; 
IR (neat, cm−1) 3536, 3093, 2958, 2925, 2852, 1748, 1536, 1482, 1352, 1307, 1201, 
1078, 805; HRMS calculated for (C14H18ClNO5)Na+ (M + Na)+: 338.07657. Found: 
338.07656. 
OO2N
Cl
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O
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2-(trimethylsilyl)ethyl-4'-(2-(hexyloxy)-2-oxoethoxy)-2'-nitro-[1,1'-biphenyl]-4-
carboxylate 53: To a sealed tube was added 46 (350 mg, 1.11 mmol), 2-
(trimethylsilyl)ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate 52 (437 mg, 
1.255 mmol), Pd2dba3 (51.7 mg, 0.0565 mmol), K3PO4 (957.5 mg, 4.52 mmol) and Sphos 
(64.9 mg, 0.158 mmol). The tube was sealed with a septa and the air was evacuated and 
pumped in N2 (g) for three cycles. Freshly distilled THF (8 mL) was added to the tube 
and then sparged with N2 (g) for 5 minutes. The vessel was then capped and heated at 
110˚C while stirring for 16 hours. The reaction was cooled, filtered over a SiO2 plug (150 
mL 25% Et2O/DCM) and concentrated to give crude. The crude was purified via flash 
SiO2 (DCM) to give the product as a yellow oil (547.9 mg, 1.09 mmol, 99%). 1H NMR 
(500 MHz, CDCl3) δ 8.07 (d, 2H, J = 8.5Hz), 7.43 (d, 1H, J = 2.65 Hz), ~ 7.36 – 7.34 
(m, 3H), 7.20 (dd, 1H, J = 2.7, 8.5 Hz), 4.730 (s, 2H), 4.44 (m, 2H), 4.24 (t, 2H, J = 6.75 
Hz), 1.67 (quint, 2H, J = 6.75 Hz), ~1.35 – 1.25 (m, 6H), 1.14 (m, 2H), 0.89 (t, 3H, 6.9 
Hz), 0.094 (s, 9H);  13C NMR (126 MHz, CDCl3) δ 168.09, 166.48, 157.87, 149.43, 
132.97, 130.35, 129.96, 129.09, 128.21, 119.47, 110.46, 66.08, 63.55, 31.47, 28.61, 
25.59, 22.64, 17.58, 14.11, -1.28; IR (neat, cm−1) 2958, 2923, 2851, 1747, 1709, 1621, 
1529, 1352, 1272, 1246, 1196, 1099; HRMS for (C26H35NO7Si)Na+ calculated: 
524.207500. Found: 524.207329. 
OO2N
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2-(trimethylsilyl)ethyl 7-(2-(hexyloxy)-2-oxoethoxy)-9H-carbazole-2-carboxylate 54: 
To a solution of 53 (59.9 mg, 0.1195 mmol) in o-dichlorobenzene (1.3 mL) was added 
PPh3 (79.9 mg, 0.305 mmol). The resulting mixture was heated to 185˚C and stirred for 
18 hours. The reaction was cooled, concentreated and purified by flash SiO2 (0-3% 
Et2O/DCM) to give the product (47.4 mg, 0.1009 mmol, 84 %) as a white solid (m.p. 151 
˚C). 1H NMR (600 MHz, CDCl3) δ 8.195 (s, 1H), 8.10 (d, 1H, J = .78 Hz), 7.97 (m, 2H), 
7.91 (dd, 1H, J = 1.41, 8.19 Hz), 6.93 (d, 1H, J = 2.16 Hz), 6.90 (dd, 1H, J = 2.19, 8.58 
Hz), 4.73 (s, 2H), 4.46 (m, 2H), 4.22 (t, 2H, J = 6.72 Hz), 1.65 (quin, 2H, J = 6.78 Hz), ~  
1.33 – 1.23 (m, 6H), 1.18 (m, 2H), 0.84 (t, 3H, J = 6.96 Hz), 0.11 (s, 9H); 13C NMR (151 
MHz, CDCl3)  δ 169.23, 167.6, 158.27, 142.08, 139.12, 127.18, 126.99, 122.19, 121.13, 
119.24, 117.56, 112.22, 109.26, 96.16, 66.05, 65.75, 63.30, 31.48, 28.64, 25.59, 22.62, 
17.64, 14.08, -1.29; IR (neat, cm−1) 3364, 2956, 2915, 2851, 1736, 1701, 1631, 1572, 
1421, 1287, 1071; HRMS calculated for (C26H34NO5Si)- (M - H)-: 468.22117. Found: 
468.22111. 
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7-(2-(hexyloxy)-2-oxoethoxy)-9H-carbazole-2-carboxylic acid 69: To a solution of 
carbazole 54 (91 mg, 0.194 mmol) in DMF ( 2.0 mL) was added tetrabutylammonium 
fluoride 1M in THF (776 µL, .776 mmol). The mixture was stirred overnight. The 
reaction was concentrated and purified by flash SiO2 (1:1 EtOAc/Hexane to 97:2:1 
EtOAc/HexHOAc) to give the product as a white solid 67.2 mg (94%). 1H NMR (600 
MHz, DMSO-d6)  δ 12.375 (s, 1H), 11.29 (s, 1H), 7.97 (m, 3H), 7.65 (dd, 1H, J = 8.15, 
1.45 Hz), 6.89 (s, 1H, J = 2.25 Hz), 6.75 (dd, 1H, J = 8.65, 2.30 Hz), 4.81 (s, 2H), 4.04 (t, 
2H, J = 6.55 Hz), 1.48 (quin, 2H, J = 6.99 Hz), 1.16 – 1.08 (m, 6H), 0.69 (t, 3H, J = 7.09 
Hz); 13C NMR (126 MHz, DMSO-d6) δ 169.41, 168.49, 158.10, 142.69, 139.61, 126.52, 
122.35, 120.21, 119.43, 116.52, 112.54, 109.19, 95.9, 65.49, 64.97, 31.25, 28.51, 25.35, 
22.37, 14.24; IR (KBr, cm-1) 3550, 2950, 2864, 1736, 1683, 1630, 1563, 1491, 1332; 
HRMS calculated for (C21H22NO5)- (M - H)- 368.15035 . Found: 368.15005. 
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bis(2-(trimethylsilyl)ethyl)-9,9'-((3,13-bis(2-(hexyloxy)-2-oxoethoxy)-16H-8,16-
methanodinaphtho[2,1-d:1',2'-g][1,3]dioxocine-4,12-diyl)bis(methylene))bis(7-(2-
(hexyloxy)-2-oxoethoxy)-9H-carbazole-2-carboxylate) 55: To a solution of carbazole 
54 (56 mg, 0.119 mmol) in DMF (3.0 mL) at 0 ºC was added LiHMDS (1M in THF) 
(113 µL, .113 mmol). The mixture was stirred for five minutes. Dibromide 44 (44.2 mg, 
0.0536) was dried in a vial, air evacuated 2 x and pump in N2 (g). The solid was then 
dissolved in DMF (3 mL)  and added via syringe to the reaction. The container and 
syringe were washed with DMF (2 x 1.5 mL) and added to the reaction. The reaction was 
continued stirring 10 minutes at 0˚C and then raised to room temperature and continued 
stirring for 16 hours. The reaction was concentrated and quenched with sat. NH4Cl and 
extracted with DCM (3 x 75 mL) to get crude. The crude was purified by flash 
chromatography (DCM) to give the product as a white solid (63.6 mg, .04 mmol) 35 %. 
1H NMR (500 MHz, CDCl3) δ 8.55 (d, 2H, J = 9.5 Hz), 7.95 (s, 2H), ~ 7.96 – 7.85 (m, 
6H), 7.68 (d, 2H, J = 8.2 Hz), 7.34 (d, 2H, 9.4 Hz), 6.96 (2H, d, 9.26 Hz), 6.84 (s, 2H), 
6.78 (dd, 2H, J = 2.1, 8.55 Hz), 6.13 (s, 1H), 5.86 (m, 4H), 5.22 (s, 1H), 4.82 (m, 4H), 
4.51 (s, 4H), 4.42 (m, 4H), 4.11 (m, 4H), 3.94 (t, 4H, J = 6.6 Hz), 2.30 (s, 2H), ~ 1.6 – 
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1.49 (m, 4H),  ~ 1.37 – 1.11 (m, 24H), ~1.10 – 0.96 (m, 8H), 0.79 (t, 6H, J = 7 Hz), 0.72 
(t, 6H, J = 7.15 Hz), .012 (s, 18H). 13C NMR (151 MHz, CDCl3) δ 169.15, 169.08, 
167.71, 158.06, 152.76, 149.11, 143.32, 140.58, 129.65, 127.58, 126.91, 126.53, 124.92, 
123.52, 121.84, 120.52, 120.3, 119.09, 119.04, 118.99, 117.05, 114.23, 111.08, 108.95, 
94.9, 91.21, 66.8, 65.69, 65.66, 65.45, 63.15, 31.45, 31.34, 28.56, 28.53, 26.98, 25.57, 
25.39, 22.57. 22.48, 17.67, 14.07, 13.99, -1.24; IR (neat, cm-1) 2954, 2921, 2852, 1761, 
1704, 1626, 1597, 1454, 1434, 1246, 1172, 1054; HRMS calculated for 
(C93H114N2O18Si2)Na+ (M + Na)+: 1625.74974. Found: 1625.74936. 
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9,9'-((3,13-bis(2-(hexyloxy)-2-oxoethoxy)-16H-8,16-methanodinaphtho[2,1-d:1',2'-
g][1,3]dioxocine-4,12-diyl)bis(methylene))bis(7-(2-(hexyloxy)-2-oxoethoxy)-9H-
carbazole-2-carboxylic acid) 56: To a solution of 55 (46.1 mg, 0.0288 mmol) in 
DMF(0.8 mL) was added TBAF, 1M in THF, ( 144µL, .144 mmol). The reaction was 
stirred for 48 hours. The reaction was concentrated and purified by flash SiO2 
chromatography (2:1 hexane/EtOAc/1:1 hexane/EtOAc/97:2:1 EtOAc/hexane/HOAc) 
and concentreated to give the product as a white solid (35.6 mg, .0254 mmol, 88%). 1H 
NMR (500 MHz, CDCl3) δ 12.63 (s, 2H), 8.78 (d, 2H, J = 9.5 Hz), 8.17 (s, 2H), 8.03 (d, 
2H, J = 8.05 Hz), 8.01 (d, 2H, J = 8.5 Hz), 7.72 (s, 2H), 7.67 (dd, 2H, J = 1.25, 5.55 Hz), 
7.50 (d, 2H, 9.55 Hz, 7.17 (s, 2H), 6.90 (d, 2H, J = 9.2 Hz), 6.79 (dd, 2H, J = 2.1, 8.6 
Hz), 6.23 (s, 1H), 5.96 (br s, 4H), 5.55 (s, 1H), 5.00 (s, 4H), 4.75 (s, 4H), 4.05 (t, 4H, J = 
6.4 Hz), 3.88 (t, 4H, 6.35 Hz), 2.26 (s, 2H), 1.43 (quin, 4H, J = 6.98 Hz), ~ 1.28 – 0.89 
(m, 24H), 0.65 (t, 6H, J = 7.12 Hz), 0.62 (t, 6H, J = 6.98 Hz); 13C NMR (151 MHz, 
CDCl3) δ 168.69, 168.66, 167.93, 127.07, 126.38, 125.98, 125.57, 123.21, 121.83, 
120.01, 119.52, 118.99, 118.81, 118.06, 115.78, 114.41, 111.21, 108.66, 94.54, 90.65, 
66.23, 64.72, 64.66, 64.41, 30.73, 30.63, 27.92, 27.80, 24.92, 24.70, 21.80, 21.74, 13.67, 
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13.64; IR (KBr, cm-1) 3416, 3068,2954, 2929, 2852, 1748, 1675, 1622, 1597, 1519, 
1458, 1433, 1393, 1332, 1258, 1176, 1098, 1058; HRMS calculated for 
(C84H92N2O17)Na+ (M + Na)+: 1425.60808. Found: 1425.60853. 
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dihexyl-2,2'-((4-((2-(2-(hexyloxy)-2-oxoethoxy)-7-(((S)-1-methoxy-1-oxopropan-2-
yl)carbamoyl)-9H-carbazol-9-yl)methyl)-12-((2-(3-(hexyloxy)-3-oxopropyl)-7-(((R)-
1-methoxy-1-oxopropan-2-yl)carbamoyl)-9H-carbazol-9-yl)methyl)-16H-8,16-
methanodinaphtho[2,1-d:1',2'-g][1,3]dioxocine-3,13-diyl)bis(oxy))diacetate  59: 56 
(50.2 mg, 0.0358 mmol) was dissolved in DMF (5 mL) with HOBT (11.6 mg, 0.0859 
mmol), DIPEA (59 µL, .358 mmol), and EDC (16.5 mg, 0.0859mmol) and stirred for 10 
minutes. L-alanine methyl ester hydrochloride (11 mg, 0.0788 mmol) was added and the 
reaction was stirred for 16 hours.The reaction was then concentrated to give crude, which 
was washed with water and extracted with DCM (3 x 50 mL) and concentrated. The 
resulting crude was then purified by flash SiO2 (DCM – 10% THF/DCM to give the 
product as a white solid (36 mg, .0229 mmol, 64%). 1H NMR (500 MHz, DMSO) δ 8.78 
(t, 2H, J = 9 Hz), 8.04 (dd, 2H, J = 2.93, 8.77 Hz), 7.99 (dd, 2H, J = 2.05, 8.55 Hz), 7.68 
(d, 2H, J = 8.25 Hz), 7.5 (dd, 2H, J = 3.75, 9.55 Hz), 7.07 (s, 1H), 7.02 (s, 1H), 6.8 (d, 
2H, J = 9.25 Hz), 6.76 (m, 2H), 6.22(s, 1H), 5.95 (m, 4H), 5.56 (s, 1H), 5.02 (s, 4H), 
4.70 (s, 2H), 4.68 (s, 2H), 4.51 (quind, 2H, J = 1.93, 7.2 Hz), 4.06 (t, 4H, J =  6.33 Hz), 
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3.88 (m, 4H), 3.65 (d, 6H, J = 1.65 Hz), 2.26 (s, 2H, 1.46 (m, 4H), 1.42 (d, 6H, J = 7.25 
Hz), ~ 1.30 – 0.90 (m, 24H), 0.70 (m, 6H), 0.64 (t, 3H, J = 7.2 Hz), 0.63 (t, 3H, J = 7.35); 
13C (126 MHz, DMSO) δ 168.79, 168.67, 166.69, 166.62, 157.44, 157.40, 152.41, 
142.55, 140.04, 129.56, 129.49, 128.73, 127.05, 125.57, 124.89, 123.19, 121.63, 119.53, 
118.99, 118.71, 11.18, 117.96, 115.95, 114.49, 108.39, 94.60, 90.64, 66.17, 64.64, 64.40, 
51.82, 48.28, 30.75, 30.62, 30.61, 27.93, 27.81, 27.79, 24.92, 24.70, 24.68, 21.84, 21.75, 
21.74, 16.87, 16.86, 13.72, 13.65; IR (neat, cm-1) 3376, 3300, 2950, 2926, 2851, 1742, 
1625, 1520, 1456, 1258, 1199, 1094, 1048; HRMS calculated for (C92H106N4O19)H+ (M 
+ H)+: 1573.73167. Found: 1573.73169. 
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2,2'-((4-((2-(((R)-1-carboxyethyl)carbamoyl)-7-(carboxymethoxy)-9H-carbazol-9-
yl)methyl)-12-((2-(((S)-1-carboxyethyl)carbamoyl)-7-(carboxymethoxy)-9H-
carbazol-9-yl)methyl)-16H-8,16-methanodinaphtho[2,1-d:1',2'-g][1,3]dioxocine-3,13-
diyl)bis(oxy))diacetic acid 60: 
To a solution of 59 (18.7 mg, .01163 mmol) in DMSO (1.2 mL) was added LiOH in H2O 
(80.6 µL, .08155 mmol, 42.48 mg/mL) and water (100 µL) and the reaction was stirred 
for three days. The flask was then placed on the vacuum for two days until dry, dissolved 
in 2 mL H2O and subjected to HPLC purification on a C18 column using a H2O/MeCN 
gradient to obtain the product as a blue solid 6.7 mg, 48%. Product was analyzed by LC-
MS for purity and mass analysis. LC-MS calculated mass (C65H53N4O20)H+  (M+H)+ : 
1209.3248, found: 1209.04; (C65H53N4O20)Na+ (M+Na)+: 1231.3073, found: 1231.31.  
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Fluorescence Titrations 
 
Figure S-1 Fluroescence titration of 60 with hexylamine in buffer (25 mM hepes, 120 
mM NaCl, pH 7.4; [60] = 10-5 M; [ Hexylamine] = .05 M,  λex = 315 nm): a) 
Fluorescence emission spectra as a funciton of added hexylamine, b) fit of titration data 
at λem = 429 nm to a single site binding isotherm, R2 = 0.9735. 
  
Figure S-2 Fluroescence titration of 60 with octylamine in buffer (25 mM hepes, 120 
mM NaCl, pH 7.4; [60] = 10-5 M; [octylamine] = .0753 M,  λex = 315 nm): a) 
Fluorescence emission spectra as a funciton of added octylamine, b) fit of titration data at 
λem = 429 nm to a single site binding isotherm, R2 = 0.9824. 
0
5 x 106
1 x 107
1.5 x 107
350 400 450 500 550 600
Free sensor
1 µL added
2 µL added
4 µL added
6 µL added
10 µL added
10 µL added
15 µL added
25 µL added
30 µL added
50 µL added
50 µL added
70 µL added
Fl
uo
re
ce
nc
e
Wavelength (nm)
00.1
0.20.3
0.40.5
0 0.005 0.01 0.015
Binding	Isotherm
0
2 106
4 106
6 106
8 106
1 107
1.2 107
350 400 450 500 550 600
Free Sensor
1 µL added
1 µL added
2 µL added
2 µL added
4 µL added
4 µL added
6 µL added
10 µL added
10 µL added
16 µL added
 20 µL added
30 µL added
50 µL added
Fl
uo
re
sc
en
ce
Wavelength (nm)
00.1
0.20.3
0.40.5
0 0.005 0.01 0.015
1-I/I0
[M]
Binding	Isotherm
	 140	
 
Figure S-5 Fluroescence titration of 60 with 1,7-diaminoheptane in buffer (25 mM hepes, 
120 mM NaCl, pH 7.4; [60] = 10-5 M; [1,7-diaminoheptane] = .04031 M,  λex = 315 nm): 
a) Fluorescence emission spectra as a funciton of added1,7-diaminooheptane, b) fit of 
titration data at λem = 429 nm to a single site binding isotherm, R2 = 0.9941. 
     
Figure S-6 Fluroescence titration of 60 with 1,8-diaminooctane in buffer (25 mM hepes, 
120 mM NaCl, pH 7.4; [60] = 2.0x10-5 M; [1,8-diaminooctane] = .0302 M,  λex = 315 
nm): a) Fluorescence emission spectra as a funciton of added 1,8-diaminooctane, b) fit of 
titration data at λem = 429 nm to a single site binding isotherm, R2 = 0.9952. 
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Figure S-7 Fluroescence titration of 60 with spermidine in buffer (25 mM hepes, 120 
mM NaCl, pH 7.4; [alanine tube] = 2.0x10-5 M; [spermidine] = .02334 M,  λex = 315 nm): 
a) Fluorescence emission spectra as a funciton of added spermidine, b) fit of titration data 
at λem = 429 nm to a single site binding isotherm, R2 = 0.9865. 
    
Figure S-8 Fluroescence titration of 60 with spermine in buffer (25 mM hepes, 120 mM 
NaCl, pH 7.4; [60] = 2.0x10-5 M; [spermine] = .01 M,  λex = 315 nm): a) Fluorescence 
emission spectra as a funciton of added spermine, b) fit of titration data at λem = 429 nm 
to a single site binding isotherm, R2 = 0.9888. 
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Figure S-9 Fluroescence titration of 60 with DMPC vesicles in buffer (25 mM hepes, 
120 mM NaCl, pH 7.4; [60] = 2.0x10-5 M; [DMPC] = .002458 M,  λex = 315 nm): a) 
Fluorescence emission spectra as a funciton of added DMPC, b) fit of titration data at λem 
= 429 nm to a single site binding isotherm, R2 = 0.4445. 
  
Figure S-10 Fluroescence titration of 60 with DMPS vesicles in buffer (25 mM hepes, 
120 mM NaCl, pH 7.4; [60] = 2.0x10-5 M; [DMPS] = .002347 M,  λex = 315 nm): a) 
Fluorescence emission spectra as a funciton of added DMPS, b) fit of titration data at λem 
= 429 nm to a single site binding isotherm, R2 = 0.9657. 
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